{"gene":"CXCR1","run_date":"2026-04-28T17:28:53","timeline":{"discoveries":[{"year":1999,"finding":"β-arrestins regulate IL-8-induced CXCR1 internalization: GRK2 and β-arrestin proteins are required for CXCR1 internalization in HEK 293 cells; a dominant-negative β-arrestin 1-V53D mutant blocks CXCR1 internalization; dynamin is also required; internalization occurs via clathrin-coated vesicles.","method":"CXCR1-GFP constructs transiently expressed in HEK 293 and RBL-2H3 cells; dominant-negative mutants (β-arrestin 1-V53D, dynamin I-K44A); co-localization with transferrin in endosomes","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — reciprocal dominant-negative mutant experiments with multiple orthogonal approaches in two cell lines","pmids":["10347185"],"is_preprint":false},{"year":1999,"finding":"IL-8-induced internalization of CXCR1 is profoundly dependent on a carboxyl-terminal region containing six phosphorylation sites, whereas CXCR2 internalization is primarily regulated by a membrane-proximal domain that lacks phosphorylation sites; both receptors recycle after ligand removal.","method":"HEK 293 cell transfectants expressing wild-type and carboxyl-tail mutants of CXCR1 and CXCR2; receptor internalization and recycling assays","journal":"Cytokine","confidence":"High","confidence_rationale":"Tier 2 — direct comparison of phosphorylation-site mutants between CXCR1 and CXCR2 with multiple functional readouts","pmids":["10623425"],"is_preprint":false},{"year":1998,"finding":"LPS down-modulates CXCR1 and CXCR2 expression on neutrophils through an agonist-independent, tyrosine kinase-dependent pathway involving p72syk hyperphosphorylation; tyrosine kinase inhibitors (genistein, herbimycin A) attenuate this down-modulation, whereas they have no effect on IL-8-induced receptor down-modulation.","method":"Flow cytometry of CXCR1/CXCR2 on human neutrophils; tyrosine kinase inhibitor experiments; ELISA for cytokines; western blot for p72syk phosphorylation","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — pharmacological inhibitor experiments with mechanistic follow-up (p72syk phosphorylation) and appropriate controls","pmids":["9712063"],"is_preprint":false},{"year":2003,"finding":"Phosphorylation of the C-tails of CXCR1 and CXCR2 is required for β-arrestin translocation and receptor internalization; C-tail-deleted and phosphorylation-deficient mutants show greater phosphoinositide hydrolysis and exocytosis but diminished chemotaxis; receptor internalization is not required for chemotaxis. CXCR2 (but not CXCR1) undergoes rapid internalization that is not fully explained by C-tail phosphorylation alone.","method":"Wild-type, chimeric, phosphorylation-deficient, and C-tail deletion mutants of CXCR1/CXCR2 expressed in RBL-2H3 cells; receptor phosphorylation, desensitization, internalization, β-arrestin 2 translocation, and chemotaxis assays","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — multiple mutant constructs with comprehensive functional readouts in a well-controlled system","pmids":["12626541"],"is_preprint":false},{"year":2004,"finding":"CXCR1 ligand selectivity is mediated by its N-terminal domain (N-domain): IL-8 binds the N-domain with higher affinity in membrane-mimicking micelles (~1 µM) than in solution (~20 µM); MGSA does not bind the N-domain in solution but binds in micelles (~3 µM); the entire N-domain interacts with the micelle in an extended fashion, with conformational restraint governing ligand-binding properties.","method":"NMR structural studies; ligand-binding in detergent micelles vs. solution; fluorescence and circular dichroism spectroscopy","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — NMR structural characterization with quantitative binding measurements in physiological membrane-mimicking environment","pmids":["15133028"],"is_preprint":false},{"year":2004,"finding":"Only the IL-8 monomer (not the dimer) is competent to bind the CXCR1 N-terminal domain; IL-8 dimerization functions as a negative regulator for receptor binding and a positive regulator for glycosaminoglycan binding.","method":"Isothermal titration calorimetry and sedimentation equilibrium to measure IL-8 binding to the CXCR1 N-domain; comparison of native IL-8 vs. monomer/dimer","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — quantitative biophysical methods (ITC + sedimentation equilibrium) directly measuring binding with mechanistic interpretation","pmids":["15252057"],"is_preprint":false},{"year":2004,"finding":"Ligand-induced endocytosis of CXCR1 and CXCR2 in primary human neutrophils requires ~10-fold higher agonist concentrations than maximal chemotaxis and calcium flux; both receptors are excluded from Triton X-100-insoluble lipid rafts and internalized via a clathrin/rab5/dynamin-dependent pathway; receptor endocytosis is not required for chemotaxis.","method":"Primary human neutrophil receptor internalization assays; calcium flux measurements; sucrose density gradient fractionation (lipid raft analysis); clathrin/dynamin pathway inhibitor experiments","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods in primary human neutrophils with rigorous concentration-response analyses","pmids":["15028716"],"is_preprint":false},{"year":2005,"finding":"Repertaxin (reparixin) acts as a noncompetitive CXCL8 inhibitor by interacting with a putative binding site in the transmembrane region of CXCR1; the binding model was confirmed by alanine scanning mutagenesis and photoaffinity labeling experiments.","method":"Molecular modeling; alanine scanning mutagenesis of CXCR1; photoaffinity labeling experiments","journal":"Journal of medicinal chemistry","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis combined with photoaffinity labeling providing direct evidence for binding site","pmids":["15974585"],"is_preprint":false},{"year":2006,"finding":"Murine CXCR1 (mCXCR1) is a functional receptor predominantly engaged by mouse GCP-2/CXCL6, human GCP-2, and IL-8/CXCL8, but not by CXCR2 ligands (ENA-78, NAP-2, GRO-α/β/γ); functional characterization via binding, GTPγS exchange stimulation, and chemotaxis of mCXCR1-transfected cells.","method":"Radioligand binding; GTPγS exchange assay; chemotaxis assay with transfected cells; RT-PCR for tissue distribution","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstitution with multiple in vitro functional assays establishing ligand selectivity","pmids":["17197447"],"is_preprint":false},{"year":2007,"finding":"IL-8 promotes bacterial killing by neutrophils through CXCR1 but not CXCR2; proteolytic cleavage of CXCR1 on neutrophils in cystic fibrosis airways disables their bacterial-killing capacity; soluble glycosylated CXCR1 fragments stimulate IL-8 production in bronchial epithelial cells via TLR2; in vivo inhalation of α1-antitrypsin restored CXCR1 expression and bacterial killing.","method":"Protease treatment of neutrophils; functional bacterial killing assays; CXCR1 fragment identification and TLR2 stimulation assays; in vivo α1-antitrypsin inhalation study in CF patients","journal":"Nature medicine","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (in vitro functional assays, receptor fragment characterization, in vivo rescue) replicated across human and in vitro models","pmids":["18059279"],"is_preprint":false},{"year":2007,"finding":"SCH527123 (Sch527123) is an allosteric antagonist of both CXCR1 and CXCR2, acting in an insurmountable (non-competitive) manner; it binds CXCR1 with Kd = 3.9 nM and CXCR2 with Kd = 0.049 nM; it inhibits CXCL1- and CXCL8-stimulated neutrophil chemotaxis and myeloperoxidase release without affecting C5a or fMLP responses.","method":"Radioligand binding ([³H]Sch527123); equilibrium and non-equilibrium binding analyses; GTPγS binding; neutrophil chemotaxis and MPO release assays; receptor selectivity panel","journal":"The Journal of pharmacology and experimental therapeutics","confidence":"High","confidence_rationale":"Tier 1 — quantitative binding characterization combined with functional assays establishing allosteric mechanism","pmids":["17496166"],"is_preprint":false},{"year":2009,"finding":"CXCR1 and CXCR2 form homo- and heterodimers in human neutrophils and cell lines; CXCL8 alters heterodimeric complexes while stabilizing homodimers and promoting receptor internalization; receptor expression level and ligand activation regulate the balance between these oligomeric states.","method":"Fluorescence resonance energy transfer (FRET) in human neutrophils and transfected cell lines; receptor expression modulation experiments","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — FRET-based direct measurement of receptor dimerization in primary human neutrophils and cell lines with multiple conditions","pmids":["19890050"],"is_preprint":false},{"year":2009,"finding":"CMV UL146 gene product vCXCL1 acts as an agonist on both CXCR1 and CXCR2 (Kd = 44 nM and 5.6 nM, respectively), inducing calcium mobilization, phosphatidylinositol turnover, and chemotaxis via these receptors, but does not activate or block any other 16 human chemokine receptors.","method":"Competition binding against radiolabeled CXCL8; calcium mobilization assays; inositol triphosphate turnover; chemotaxis assays in CXCR1/CXCR2-expressing CHO, 300.19, COS7, and L1.2 cells","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — reconstituted functional assays with quantitative binding across full receptor panel","pmids":["20044480"],"is_preprint":false},{"year":2010,"finding":"CXCR1 blockade in breast cancer stem cells (CSCs) depletes the CSC population and induces massive apoptosis in the bulk tumor via FASL/FAS signaling; these effects are mediated by the FAK/AKT/FOXO3A pathway.","method":"CXCR1-specific blocking antibody and repertaxin (small-molecule inhibitor); in vitro CSC depletion assays; apoptosis assays; pathway inhibitor studies (FAK/AKT/FOXO3A); human breast cancer xenografts in mice","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (antibody + small molecule, in vitro + in vivo) with defined pathway placement","pmids":["20051626"],"is_preprint":false},{"year":2012,"finding":"DF 2156A, a dual CXCR1/CXCR2 inhibitor, acts as a non-competitive allosteric inhibitor; polar interactions stabilized by a direct ionic bond between DF 2156A and Lys99 on CXCR1 (and non-conserved Asp293 on CXCR2) are key determinants of binding; it blocks signal transduction leading to chemotaxis without altering natural ligand binding affinity.","method":"Radioligand and [³⁵S]-GTPγS binding; chemotaxis of L1.2 transfectants and human leukocytes; murine models of angiogenesis and liver ischemia/reperfusion; molecular characterization of binding mode","journal":"British journal of pharmacology","confidence":"High","confidence_rationale":"Tier 1 — site-specific binding characterization (ionic bond to Lys99) combined with functional assays and in vivo validation","pmids":["21718305"],"is_preprint":false},{"year":2013,"finding":"Staphylococcus aureus LukED toxin targets CXCR1 and CXCR2 on neutrophils; the LukE subunit binds neutrophils in a specific and saturable manner, and this binding is inhibited by CXCL8 (the high-affinity endogenous ligand); CXCR1/2 targeting by LukED promotes killing of monocytes and neutrophils in vitro and facilitates lethality in bacteremic mice.","method":"Saturation binding assays; CXCL8 competition binding; in vitro cytotoxicity assays with CXCR1/2-expressing cells; murine systemic infection model with LukED-deficient bacteria","journal":"Cell host & microbe","confidence":"High","confidence_rationale":"Tier 2 — saturable and competitive binding assays in primary cells combined with in vivo genetic validation","pmids":["24139401"],"is_preprint":false},{"year":2015,"finding":"CXCR1-mediated neutrophil degranulation (not chemotaxis) is critical for fungal killing; Cxcr1-/- mice show decreased survival and enhanced Candida growth in the kidney due to a cell-intrinsic defect in neutrophil degranulation; the human mutant CXCR1-T276 allele also results in impaired neutrophil degranulation and fungal killing.","method":"Cxcr1-/- mouse generation; systemic candidiasis model; neutrophil trafficking and degranulation assays; human CXCR1-T276 variant functional studies; patient genetic association","journal":"Science translational medicine","confidence":"High","confidence_rationale":"Tier 2 — knockout mouse model with defined cellular phenotype (degranulation) confirmed in human variant, replicated across mouse and human","pmids":["26791948"],"is_preprint":false},{"year":2015,"finding":"CXCR1 couples to G proteins through its DRY motif: D134(3.49) mutations (D134N, D134V) completely abolish ligand binding and functional response of CXCR1; point mutations M241(6.34) and F251(6.44) on TM6 generate mutant receptors with modest constitutive activity via Gα15 signaling, identifying a 'hot spot' for CXCR1 activation.","method":"Alanine/point mutagenesis of CXCR1; radioligand binding; calcium mobilization assays; G protein activation (Gα15) assays in transfected cells","journal":"FEBS open bio","confidence":"High","confidence_rationale":"Tier 1 — site-directed mutagenesis with multiple functional readouts establishing catalytic/coupling mechanism","pmids":["25834784"],"is_preprint":false},{"year":2000,"finding":"IL-8 stimulation of CXCR1 or CXCR2 cross-phosphorylates CCR1 and cross-desensitizes its ability to stimulate GTPase activity and Ca2+ mobilization; CCR1 cross-phosphorylates and cross-desensitizes CXCR2 but not CXCR1, revealing selective asymmetric cross-regulation among chemokine receptors.","method":"RBL-2H3 cells co-expressing CCR1 with CXCR1, CXCR2, or phosphorylation-deficient CXCR2-331T; receptor phosphorylation, GTPase stimulation, Ca2+ mobilization, and internalization assays","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple phosphorylation and functional assays in co-expressing cells with mechanistic mutant controls","pmids":["10734056"],"is_preprint":false},{"year":2001,"finding":"IL-8 acutely reduces Ca2+ currents in cholinergic septal neurons expressing CXCR1 and CXCR2 mRNAs via closure of L- and N-type Ca2+ channels and activation of Giα1 and/or Giα2 G-protein subtypes; this is the first report of CXCR1 mRNA expression in the brain and of a chemokine modulating ion channels in neurons via G-proteins.","method":"Whole-cell patch clamp recording; single-cell RT-PCR from recorded neurons; pharmacological G-protein dissection","journal":"Journal of neurochemistry","confidence":"High","confidence_rationale":"Tier 2 — electrophysiology with single-cell RT-PCR directly linking CXCR1 expression to functional ion channel modulation","pmids":["11553670"],"is_preprint":false},{"year":2001,"finding":"CXCR1 (but not CXCR2) on uroepithelial cells mediates neutrophil transepithelial migration; anti-CXCR1 antibodies inhibit IL-8-dependent neutrophil migration across infected epithelial layers by ~60%; IL-8 receptor knockout mice fail to express the receptor on mucosal cells and cannot translocate neutrophils across the epithelial barrier.","method":"Antibody blocking of CXCR1 and CXCR2 in epithelial monolayer migration assays; IL-8 receptor knockout mouse model; experimental urinary tract infection model","journal":"Journal of immunology","confidence":"High","confidence_rationale":"Tier 2 — receptor-specific antibody blockade in vitro confirmed by genetic knockout in vivo","pmids":["11046063"],"is_preprint":false},{"year":2016,"finding":"CXCR1 and CXCR2 differentially regulate hepatocyte exosome release: CXCR1-deficient hepatocytes produce fewer exosomes and lack packaging of neutral ceramidase and sphingosine kinase enzymes required for exosome-mediated hepatocyte proliferation; CXCR2-deficient hepatocytes produce more exosomes via increased neutral sphingomyelinase activity and intracellular ceramide.","method":"CXCR1-/- and CXCR2-/- hepatocyte isolation; exosome quantification; neutral sphingomyelinase activity assays; enzyme content analysis of exosomes; hepatocyte proliferation assays","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — genetic knockout with mechanistic enzyme activity follow-up, single lab","pmids":["27551720"],"is_preprint":false},{"year":2016,"finding":"REEP5 and REEP6 are accessory proteins that interact specifically with CXCR1 (but not CXCR2); they facilitate ligand-stimulated endocytosis of CXCR1 and intracellular clustering of β-arrestin2 after IL-8 treatment, rather than membrane expression of CXCR1; their depletion reduces CXCR1-mediated ERK phosphorylation, actin polymerization, and cancer cell invasion.","method":"Co-immunoprecipitation (CXCR1-REEP5/6 interaction); overexpression and siRNA knockdown; receptor internalization and β-arrestin2 clustering assays; ERK phosphorylation western blot; xenograft tumor model","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — Co-IP plus functional rescue/knockdown experiments, single lab","pmids":["27966653"],"is_preprint":false},{"year":2018,"finding":"CXCL8-CXCR1 signaling in astrocytes activates NF-κB to upregulate IL-8 expression; in neurons, CXCR1 mediates methamphetamine-induced apoptosis via astrocyte-released IL-8; siRNA knockdown of CXCR1 in SH-SY5Y neurons reduces cleaved caspase-3 and PARP expression, and this protection is reversed by recombinant IL-8.","method":"siRNA knockdown of CXCR1 in SH-SY5Y cells; co-culture of neurons and astrocytes; western blot for apoptosis markers (caspase-3, PARP); NF-κB pathway analysis; in vivo mouse METH model","journal":"Frontiers in cellular neuroscience","confidence":"Medium","confidence_rationale":"Tier 2 — siRNA knockdown with pathway rescue experiment, single lab","pmids":["30123110"],"is_preprint":false},{"year":2018,"finding":"Differential CXCL8 post-translational modifications (citrullination at position 5, N-terminal truncation to CXCL8(6-77)) enhance CXCR1 internalization and Gαi-dependent signaling; all CXCL8 variants promote β-arrestin 1 and 2 recruitment to CXCR1 and CXCR2; modifications do not alter the preference (bias) between Gαi-protein and β-arrestin signaling.","method":"Chemically synthesized native and modified CXCL8 variants; internalization assays in human neutrophils; Gαi signaling assays; β-arrestin 1/2 recruitment assays","journal":"International journal of molecular sciences","confidence":"Medium","confidence_rationale":"Tier 2 — chemically defined ligand variants with multiple signaling readouts, single lab","pmids":["30486423"],"is_preprint":false},{"year":2001,"finding":"CD28 cross-linking on human neutrophils causes early upregulation of CXCR1 surface expression and concurrent increase in IL-8-induced chemotaxis, followed by receptor internalization and reduced chemotaxis at 3 hours; this demonstrates CD28-mediated regulation of CXCR1 expression and neutrophil migration.","method":"CD28 cross-linking with anti-CD28 mAb; flow cytometry for CXCR1 expression; chemotaxis assays; immunoprecipitation","journal":"European journal of immunology","confidence":"Medium","confidence_rationale":"Tier 2 — antibody cross-linking with functional migration readout, single lab","pmids":["11465111"],"is_preprint":false},{"year":2002,"finding":"Phagocytosis down-regulates CXCR1 and CXCR2 surface expression on neutrophils via metalloproteinase-dependent proteolytic degradation (not internalization); metalloproteinase inhibitor 1,10-phenanthroline prevents this reduction; down-regulation is accompanied by reduced Ca2+ responses to corresponding ligands.","method":"Phagocytosis of opsonized yeast; flow cytometry for CXCR1/CXCR2; metalloproteinase inhibitor (1,10-phenanthroline); confocal microscopy; Ca2+ response assays","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 — pharmacological inhibitor plus confocal microscopy distinguishing proteolysis from internalization","pmids":["12239185"],"is_preprint":false},{"year":2001,"finding":"TNF-α mediates S. aureus-induced down-regulation of CXCR1 and CXCR2 on neutrophils in whole blood; anti-TNF-α antibody abrogates this down-regulation; TNF-α-mediated decrease is associated with lower CXCR1/CXCR2 mRNA levels and is abrogated by protease inhibitors, indicating both transcriptional and proteolytic mechanisms.","method":"Whole blood stimulation with S. aureus; anti-TNF-α antibody blockade; flow cytometry; RT-PCR for mRNA; protease inhibitor experiments","journal":"Clinical and experimental immunology","confidence":"Medium","confidence_rationale":"Tier 2 — antibody neutralization with transcriptional and proteolytic mechanistic dissection, single lab","pmids":["11531949"],"is_preprint":false},{"year":2010,"finding":"The CXCR1 N-terminal domain (34-mer peptide) interacts with phospholipid membranes (DOPC vesicles), causing motional restriction of tryptophan residues, increased fluorescence anisotropy, red edge excitation shift (REES) of 19 nm, and increased mean fluorescence lifetime; the entire N-domain interacts with the membrane in an extended fashion.","method":"Fluorescence spectroscopy (tryptophan emission, anisotropy, REES, lifetime); surface pressure measurements with DOPC vesicles","journal":"Biochimica et biophysica acta","confidence":"Medium","confidence_rationale":"Tier 1 — quantitative biophysical characterization of N-domain membrane interaction, single lab","pmids":["20226759"],"is_preprint":false},{"year":2017,"finding":"Human CD8+ T cells store CXCR1 in a distinct intracellular compartment (partially co-localizing with Golgi marker GM130, early endosome marker EEA1, and constitutive secretory pathway marker β2-microglobulin, but not with perforin, RANTES, or lysosomal CD63) and rapidly up-regulate it to the cell surface within minutes of activation by neutrophil supernatants (not TCR cross-linking); CXCR1 up-regulation enables functional IL-8-directed migration.","method":"Immunofluorescence microscopy with organelle markers; flow cytometry; chemotaxis assay; kinetic surface expression assay","journal":"Blood","confidence":"Medium","confidence_rationale":"Tier 2 — direct localization by immunofluorescence microscopy with defined functional consequence (chemotaxis), single lab","pmids":["16081690"],"is_preprint":false},{"year":2017,"finding":"In zebrafish, cxcl8/cxcr1 signaling in endothelial cells positively regulates HSPC colonization of the caudal hematopoietic tissue (CHT) by increasing HSPC-endothelial cell 'cuddling', HSPC residency time, and mitotic rate; enhanced cxcr1 signaling induces an increase in CHT volume and cxcl12a expression; cxcr1 acts in a HSPC-nonautonomous manner to improve donor HSPC engraftment.","method":"Single-cell tracking (live imaging) of fluorescent HSPCs in zebrafish CHT; cxcr1 mutants; parabiotic zebrafish; pharmacological cxcr1 manipulation; measurement of HSPC-endothelial interactions","journal":"The Journal of experimental medicine","confidence":"Medium","confidence_rationale":"Tier 2 — live single-cell imaging with genetic mutant validation in zebrafish, single lab","pmids":["28351983"],"is_preprint":false},{"year":2023,"finding":"CXCR1 drives dendritic cell-mediated inflammation via a CXCL5/CXCR1/HIF-1α positive feedback loop that directly regulates IL-6/IL-12p70 production; DC-specific CXCR1 knockout reduces inflammatory cytokine production and ameliorates EAE disease severity and LPS-induced ARDS lung injury.","method":"Global and DC-specific CXCR1 knockout mice; EAE and LPS-induced ARDS models; cytokine profiling (IL-6, IL-12p70); mechanistic pathway analysis (HIF-1α); CXCL5 antibody neutralization","journal":"Cell death & disease","confidence":"Medium","confidence_rationale":"Tier 2 — cell-type-specific knockout with defined positive feedback mechanism, single lab","pmids":["37709757"],"is_preprint":false},{"year":2001,"finding":"The second intracellular domain of CXCR1 has a major influence on signaling via inhibitory G proteins; replacing the second intracellular domain of CXCR1 with that of CXCR5 strongly reduces ERK1/2-MAP kinase activation and chemotaxis despite retained Gi coupling; the third and C-terminal intracellular domains of CXCR5 have only minor effects on signal transduction.","method":"Chimeric CXCR1/CXCR5 receptor constructs; pertussis toxin sensitivity assays; Ca2+ signaling; ERK1/2 MAP kinase activation; chemotaxis assays","journal":"Biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — domain-swap mutagenesis with multiple signaling pathway readouts, single lab","pmids":["11688722"],"is_preprint":false},{"year":2016,"finding":"IL-8 promotes HNSCC cell proliferation via CXCR1/2-mediated activation of the NOD1/RIP2 signaling pathway; IL-8 siRNA knockdown reduces CXCR1/2 expression and NOD1/RIP2 signaling; NOD1 and RIP2 expression is increased by IL-8 stimulation and reduced by IL-8 siRNA, while NOD2 shows an opposite pattern.","method":"siRNA knockdown of IL-8 and CXCR1/2 in HNSCC cell lines; proliferation and clonogenicity assays; western blot and RT-PCR for NOD1, NOD2, RIP2","journal":"Oncotarget","confidence":"Low","confidence_rationale":"Tier 3 — siRNA knockdown linking CXCR1/2 to NOD1/RIP2 pathway, single lab, limited mechanistic follow-up","pmids":["27557518"],"is_preprint":false},{"year":2019,"finding":"CXCR1 promotes gastric cancer cell proliferation, migration, and invasion through AKT and ERK1/2 phosphorylation; CXCR1 knockdown reduces cyclin D1, EGFR, VEGF, MMP-9, MMP-2, and Bcl-2 while increasing Bax and E-cadherin; CXCR1 overexpression enhances tumor growth in vivo.","method":"Stable shRNA knockdown and overexpression in gastric cancer cell lines; MTT, colony formation, flow cytometry, transwell assays; western blot for signaling molecules; xenograft mouse model","journal":"International journal of oncology","confidence":"Low","confidence_rationale":"Tier 3 — stable KD/OE with signaling readouts, single lab, pathway placement inferred rather than directly established","pmids":["26983663"],"is_preprint":false}],"current_model":"CXCR1 is a G protein-coupled chemokine receptor that binds IL-8/CXCL8 (and related ELR-CXC chemokines) with high selectivity through a two-site mechanism involving its N-terminal domain and juxtamembrane domain; upon ligand binding it activates Gi proteins (requiring the conserved DRY motif residue D134), triggers downstream signaling cascades (ERK1/2, AKT, PI3K, phospholipase C, Ca2+ flux), undergoes GRK2-mediated C-tail phosphorylation that drives β-arrestin recruitment and clathrin/dynamin-dependent internalization, and mediates critical neutrophil functions including transepithelial migration and degranulation-dependent bacterial/fungal killing, while forming homo- and heterodimers with CXCR2 that dynamically regulate signaling balance."},"narrative":{"teleology":[{"year":1998,"claim":"Establishing that CXCR1 surface expression is regulated independently of its own ligand: LPS down-modulates CXCR1 on neutrophils through an agonist-independent, tyrosine kinase (p72syk)-dependent mechanism, revealing that receptor availability is controlled by innate immune signals beyond IL-8.","evidence":"Flow cytometry on human neutrophils with tyrosine kinase inhibitors and p72syk phosphorylation western blot","pmids":["9712063"],"confidence":"High","gaps":["Identity of kinases downstream of p72syk mediating receptor loss not determined","Whether LPS causes receptor internalization vs. shedding vs. transcriptional suppression not fully resolved"]},{"year":1999,"claim":"Defining the endocytic machinery for CXCR1: β-arrestin recruitment, GRK2-mediated phosphorylation, and dynamin/clathrin-dependent internalization were shown to be required, and the six C-terminal phosphorylation sites were identified as the primary internalization determinant—distinguishing CXCR1 from CXCR2 whose internalization relies on a membrane-proximal domain.","evidence":"Dominant-negative β-arrestin 1-V53D and dynamin K44A mutants in HEK293 and RBL-2H3 cells; C-tail truncation and phosphorylation-site mutants with recycling assays","pmids":["10347185","10623425"],"confidence":"High","gaps":["Specific GRK2 phosphorylation sites within the six-site cluster not mapped individually","Whether other GRKs contribute in primary neutrophils not addressed"]},{"year":2000,"claim":"Revealing asymmetric cross-talk between chemokine receptors: IL-8/CXCR1 stimulation cross-phosphorylates and desensitizes CCR1, but CCR1 activation cannot reciprocally cross-desensitize CXCR1, establishing a signaling hierarchy among co-expressed chemokine receptors.","evidence":"RBL-2H3 cells co-expressing CCR1 with CXCR1 or CXCR2; receptor phosphorylation, GTPase, and Ca²⁺ assays with phosphorylation-deficient mutant controls","pmids":["10734056"],"confidence":"High","gaps":["Kinase responsible for heterologous CXCR1→CCR1 phosphorylation not identified","Relevance of this hierarchy in primary neutrophils co-expressing multiple receptors not tested"]},{"year":2001,"claim":"Identifying CXCR1's non-redundant role in transepithelial neutrophil migration: antibody blockade and receptor knockout showed that CXCR1 (not CXCR2) on uroepithelial cells is required for neutrophil transmigration across infected mucosal barriers, linking CXCR1 to mucosal innate defense.","evidence":"Anti-CXCR1/CXCR2 blocking antibodies in epithelial migration assays; IL-8 receptor knockout mice with experimental UTI","pmids":["11046063"],"confidence":"High","gaps":["Whether epithelial CXCR1 acts by transcytosing IL-8 or by direct signaling in epithelial cells not resolved","Contribution of CXCR1 on other mucosal surfaces not tested"]},{"year":2001,"claim":"Demonstrating CXCR1 function outside the immune system: IL-8 acting through CXCR1 in cholinergic septal neurons closes L- and N-type Ca²⁺ channels via Giα1/Giα2, establishing that CXCR1 modulates neuronal excitability.","evidence":"Whole-cell patch clamp with single-cell RT-PCR from rat septal neurons; pharmacological G-protein subtype dissection","pmids":["11553670"],"confidence":"High","gaps":["Physiological role of CXCR1 in brain function not defined","Whether neuronal CXCR1 undergoes the same internalization/desensitization as in immune cells unknown"]},{"year":2001,"claim":"Mapping the intracellular domain architecture for G-protein signaling: the second intracellular loop of CXCR1 was identified as the major determinant of Gi-coupled ERK1/2 activation and chemotaxis through domain-swap chimeras with CXCR5.","evidence":"CXCR1/CXCR5 chimeric receptors assayed for pertussis toxin sensitivity, Ca²⁺ flux, ERK1/2 phosphorylation, and chemotaxis","pmids":["11688722"],"confidence":"Medium","gaps":["Specific residues within ICL2 mediating Gi coupling not identified","Single-lab chimeric study without independent replication"]},{"year":2003,"claim":"Dissecting the functional consequences of C-tail phosphorylation: phosphorylation-deficient mutants showed that C-tail phosphorylation is required for β-arrestin translocation and internalization but dispensable for—and actually inhibitory toward—phosphoinositide hydrolysis, exocytosis, and chemotaxis, uncoupling desensitization from effector function.","evidence":"Wild-type, chimeric, and phosphorylation-deficient CXCR1/CXCR2 mutants in RBL-2H3 cells with comprehensive signaling readouts","pmids":["12626541"],"confidence":"High","gaps":["Whether constitutive (non-ligand-dependent) phosphorylation occurs and affects basal trafficking not tested","Role of individual phosphosites in graded β-arrestin recruitment not resolved"]},{"year":2004,"claim":"Resolving the structural basis of ligand selectivity: NMR and biophysical studies showed that the CXCR1 N-terminal domain selectively binds the IL-8 monomer (not dimer) in a membrane-dependent conformation, with ITC quantifying binding affinity and establishing that IL-8 dimerization is a negative regulator of receptor engagement.","evidence":"NMR in detergent micelles; ITC and sedimentation equilibrium comparing IL-8 monomer vs. dimer binding to CXCR1 N-domain peptide","pmids":["15133028","15252057"],"confidence":"High","gaps":["Full-length receptor–ligand structure not determined","How the N-domain binding step couples to TM domain activation (two-site mechanism) not structurally resolved"]},{"year":2004,"claim":"Establishing the agonist concentration threshold for internalization in primary neutrophils: receptor endocytosis requires ~10-fold higher IL-8 concentrations than chemotaxis and Ca²⁺ flux, and both receptors are excluded from lipid rafts, clarifying that internalization is a high-dose response separable from migration.","evidence":"Dose-response internalization, Ca²⁺ flux, and sucrose gradient fractionation in primary human neutrophils with clathrin/dynamin pathway inhibitors","pmids":["15028716"],"confidence":"High","gaps":["Whether sustained low-dose exposure eventually drives internalization not assessed","Mechanism of lipid raft exclusion not defined"]},{"year":2005,"claim":"Identifying the transmembrane allosteric binding pocket: repertaxin was shown to inhibit CXCR1 non-competitively by binding within the transmembrane region, validated by alanine scanning mutagenesis and photoaffinity labeling.","evidence":"Molecular modeling; systematic alanine mutagenesis of CXCR1 TM residues; photoaffinity labeling","pmids":["15974585"],"confidence":"High","gaps":["Atomic-resolution structure of the repertaxin–CXCR1 complex not available","Whether TM allosteric site is conserved across species not tested"]},{"year":2007,"claim":"Linking CXCR1 proteolysis to impaired host defense in cystic fibrosis: neutrophil-surface CXCR1 cleavage by airway proteases abolished bacterial killing capacity (which required CXCR1 but not CXCR2), and shed CXCR1 fragments amplified inflammation via TLR2; α1-antitrypsin inhalation restored CXCR1 and bacterial killing in CF patients.","evidence":"Protease-treated neutrophils with bacterial killing assays; TLR2 stimulation by CXCR1 fragments; in vivo α1-antitrypsin inhalation in CF patients","pmids":["18059279"],"confidence":"High","gaps":["Specific protease(s) cleaving CXCR1 in CF airways not definitively identified","Mechanism by which CXCR1 (but not CXCR2) supports bacterial killing not molecularly resolved"]},{"year":2009,"claim":"Demonstrating receptor dimerization dynamics: FRET in primary neutrophils showed that CXCR1 forms homo- and heterodimers with CXCR2; CXCL8 stabilizes homodimers while remodeling heterodimeric complexes, indicating that oligomeric state is a regulatable signaling parameter.","evidence":"FRET measurements in human neutrophils and transfected cell lines under varying receptor expression and ligand conditions","pmids":["19890050"],"confidence":"High","gaps":["Functional consequence of homodimer vs. heterodimer signaling not determined","Structural basis of dimer interface unknown"]},{"year":2010,"claim":"Establishing CXCR1 as a breast cancer stem cell vulnerability: CXCR1 blockade depleted CSCs and triggered bystander apoptosis in bulk tumor cells through FASL/FAS signaling downstream of FAK/AKT/FOXO3A, positioning CXCR1 as a therapeutic target in breast cancer.","evidence":"CXCR1 blocking antibody and repertaxin in vitro and in human breast cancer xenografts; FAK/AKT/FOXO3A pathway inhibitor dissection","pmids":["20051626"],"confidence":"High","gaps":["Whether CXCR1 marks a functionally distinct CSC subset or is universally expressed on CSCs unclear","Mechanism linking CXCR1 blockade specifically to FASL upregulation not fully dissected"]},{"year":2015,"claim":"Confirming the essential DRY motif and identifying a TM6 activation hotspot: D134 mutations abolished both ligand binding and signaling, while M241/F251 mutations on TM6 generated constitutive activity, mapping the structural requirements for CXCR1 activation.","evidence":"Site-directed mutagenesis with radioligand binding, Ca²⁺ mobilization, and G15 activation assays in transfected cells","pmids":["25834784"],"confidence":"High","gaps":["No full active-state structure to contextualize the TM6 mutations","Whether TM6 constitutive-activity mutants signal through Gi or only promiscuous G15 not clarified"]},{"year":2015,"claim":"Demonstrating CXCR1's non-redundant role in antifungal defense through degranulation: Cxcr1−/− mice had impaired neutrophil degranulation (not chemotaxis) and increased mortality in systemic candidiasis, and the human CXCR1-T276 variant recapitulated this degranulation defect, linking a specific cellular function to host antifungal immunity.","evidence":"Cxcr1−/− mouse systemic candidiasis model; neutrophil degranulation and trafficking assays; human CXCR1-T276 variant functional studies and genetic association","pmids":["26791948"],"confidence":"High","gaps":["Signaling pathway connecting CXCR1 specifically to degranulation machinery not defined","CXCR1-T276 patient cohort limited; broader replication needed"]},{"year":2016,"claim":"Identifying REEP5/REEP6 as CXCR1-specific accessory proteins: Co-IP showed these ER-shaping proteins interact selectively with CXCR1, facilitating its ligand-stimulated endocytosis, β-arrestin2 clustering, and downstream ERK signaling rather than surface trafficking.","evidence":"Co-immunoprecipitation; siRNA knockdown and overexpression of REEP5/6; CXCR1 internalization, β-arrestin2 clustering, and ERK phosphorylation assays","pmids":["27966653"],"confidence":"Medium","gaps":["Reciprocal Co-IP and endogenous interaction not confirmed","Structural basis of REEP5/6 selectivity for CXCR1 over CXCR2 unknown","Single-lab finding not independently replicated"]},{"year":2023,"claim":"Extending CXCR1's role to dendritic cell biology: DC-specific CXCR1 knockout revealed a CXCL5/CXCR1/HIF-1α positive feedback loop driving IL-6/IL-12p70 production in inflammatory disease models (EAE, ARDS), expanding CXCR1 function beyond neutrophils.","evidence":"DC-specific CXCR1 knockout mice in EAE and LPS-ARDS models; cytokine profiling; HIF-1α pathway analysis; CXCL5 neutralization","pmids":["37709757"],"confidence":"Medium","gaps":["Whether HIF-1α is a direct transcriptional target of CXCR1 signaling or secondary to metabolic changes not resolved","Single-lab finding; independent replication in other DC-driven disease models needed"]},{"year":null,"claim":"A high-resolution structure of CXCR1 in complex with monomeric IL-8 (or other ligands) and coupled G-protein has not been determined; the molecular basis for CXCR1's selective coupling to degranulation (but not chemotaxis) pathways, the identity of the protease(s) cleaving CXCR1 in disease airways, and the functional significance of CXCR1/CXCR2 dimer stoichiometry in vivo remain open questions.","evidence":"","pmids":[],"confidence":"Low","gaps":["No full-length CXCR1–IL-8–Gi cryo-EM or crystal structure","Signaling branch point distinguishing degranulation from chemotaxis downstream of CXCR1 unknown","CXCR1/CXCR2 heterodimer functional consequences in vivo undefined"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[8,12,17]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[18,11]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,6,11,26]},{"term_id":"GO:0005768","term_label":"endosome","supporting_discovery_ids":[0,6,29]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[0,29]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[9,16,20,31]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,13,17,19,32]},{"term_id":"R-HSA-9609507","term_label":"Protein localization","supporting_discovery_ids":[0,1,3,6]}],"complexes":["CXCR1 homodimer","CXCR1/CXCR2 heterodimer"],"partners":["CXCR2","ARRB1","ARRB2","GRK2","CXCL8","REEP5","REEP6","CCR1"],"other_free_text":[]},"mechanistic_narrative":"CXCR1 is a Gi-coupled chemokine receptor that selectively binds monomeric IL-8/CXCL8 through a two-site mechanism involving its N-terminal domain and transmembrane regions, activating downstream ERK1/2, AKT, phospholipase C, and Ca²⁺ signaling cascades to drive neutrophil chemotaxis, degranulation, and transepithelial migration [PMID:15133028, PMID:15252057, PMID:11046063, PMID:26791948]. Ligand-induced receptor desensitization requires GRK2-mediated C-tail phosphorylation at six key sites, which recruits β-arrestin and triggers clathrin/dynamin-dependent internalization, while the DRY motif residue D134 is essential for G-protein coupling and ligand binding [PMID:10347185, PMID:10623425, PMID:12626541, PMID:25834784]. CXCR1 forms homo- and heterodimers with CXCR2 whose balance is dynamically regulated by CXCL8, and it cross-phosphorylates CCR1 but is itself resistant to CCR1-mediated cross-desensitization, establishing an asymmetric chemokine receptor signaling hierarchy [PMID:19890050, PMID:10734056]. Beyond neutrophils, CXCR1 mediates neuronal Ca²⁺ channel modulation via Giα, drives dendritic cell inflammatory cytokine production through a CXCL5/HIF-1α feedback loop, regulates breast cancer stem cell survival via FAK/AKT/FOXO3A, and its proteolytic cleavage in cystic fibrosis airways disables neutrophil bactericidal capacity [PMID:11553670, PMID:37709757, PMID:20051626, PMID:18059279]."},"prefetch_data":{"uniprot":{"accession":"P25024","full_name":"C-X-C chemokine receptor type 1","aliases":["CDw128a","High affinity interleukin-8 receptor A","IL-8R A","IL-8 receptor type 1"],"length_aa":350,"mass_kda":39.8,"function":"Receptor to interleukin-8, which is a powerful neutrophils chemotactic factor (PubMed:1840701). Binding of IL-8 to the receptor causes activation of neutrophils. This response is mediated via a G-protein that activates a phosphatidylinositol-calcium second messenger system (PubMed:8662698)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/P25024/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CXCR1","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CXCR1","total_profiled":1310},"omim":[{"mim_id":"609423","title":"HUMAN IMMUNODEFICIENCY VIRUS TYPE 1, SUSCEPTIBILITY TO","url":"https://www.omim.org/entry/609423"},{"mim_id":"153620","title":"MACROPHAGE MIGRATION INHIBITORY FACTOR; MIF","url":"https://www.omim.org/entry/153620"},{"mim_id":"146929","title":"CHEMOKINE, CXC MOTIF, RECEPTOR 1; CXCR1","url":"https://www.omim.org/entry/146929"},{"mim_id":"146928","title":"CHEMOKINE, CXC MOTIF, RECEPTOR 2; CXCR2","url":"https://www.omim.org/entry/146928"},{"mim_id":"138965","title":"CHEMOKINE, CXC MOTIF, LIGAND 6; CXCL6","url":"https://www.omim.org/entry/138965"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"adipose tissue","ntpm":12.3},{"tissue":"lymphoid tissue","ntpm":38.8}],"url":"https://www.proteinatlas.org/search/CXCR1"},"hgnc":{"alias_symbol":["CKR-1","CDw128a","CD181"],"prev_symbol":["CMKAR1","IL8RA"]},"alphafold":{"accession":"P25024","domains":[{"cath_id":"1.20.1070.10","chopping":"35-313","consensus_level":"high","plddt":84.4139,"start":35,"end":313}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P25024","model_url":"https://alphafold.ebi.ac.uk/files/AF-P25024-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P25024-F1-predicted_aligned_error_v6.png","plddt_mean":78.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CXCR1","jax_strain_url":"https://www.jax.org/strain/search?query=CXCR1"},"sequence":{"accession":"P25024","fasta_url":"https://rest.uniprot.org/uniprotkb/P25024.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P25024/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P25024"}},"corpus_meta":[{"pmid":"32289253","id":"PMC_32289253","title":"CXCR1 and CXCR2 Chemokine Receptor Agonists Produced by Tumors Induce Neutrophil Extracellular Traps that Interfere with Immune Cytotoxicity.","date":"2020","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/32289253","citation_count":635,"is_preprint":false},{"pmid":"28529637","id":"PMC_28529637","title":"Role of the CXCL8-CXCR1/2 Axis in Cancer and Inflammatory Diseases.","date":"2017","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/28529637","citation_count":611,"is_preprint":false},{"pmid":"20051626","id":"PMC_20051626","title":"CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts.","date":"2010","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/20051626","citation_count":593,"is_preprint":false},{"pmid":"27578214","id":"PMC_27578214","title":"The CXCL8-CXCR1/2 pathways in cancer.","date":"2016","source":"Cytokine & growth factor reviews","url":"https://pubmed.ncbi.nlm.nih.gov/27578214","citation_count":521,"is_preprint":false},{"pmid":"31488817","id":"PMC_31488817","title":"CXCR1- or CXCR2-modified CAR T cells co-opt IL-8 for maximal antitumor efficacy in solid tumors.","date":"2019","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/31488817","citation_count":318,"is_preprint":false},{"pmid":"18059279","id":"PMC_18059279","title":"Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease.","date":"2007","source":"Nature medicine","url":"https://pubmed.ncbi.nlm.nih.gov/18059279","citation_count":263,"is_preprint":false},{"pmid":"31848188","id":"PMC_31848188","title":"Inhibition of MDSC Trafficking with SX-682, a CXCR1/2 Inhibitor, Enhances NK-Cell Immunotherapy in Head and Neck Cancer Models.","date":"2019","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/31848188","citation_count":235,"is_preprint":false},{"pmid":"17197447","id":"PMC_17197447","title":"Murine CXCR1 is a functional receptor for GCP-2/CXCL6 and interleukin-8/CXCL8.","date":"2006","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/17197447","citation_count":175,"is_preprint":false},{"pmid":"24139401","id":"PMC_24139401","title":"Staphylococcus aureus leukotoxin ED targets the chemokine receptors CXCR1 and CXCR2 to kill leukocytes and promote infection.","date":"2013","source":"Cell host & microbe","url":"https://pubmed.ncbi.nlm.nih.gov/24139401","citation_count":138,"is_preprint":false},{"pmid":"11046063","id":"PMC_11046063","title":"Transepithelial neutrophil migration is CXCR1 dependent in vitro and is defective in IL-8 receptor knockout mice.","date":"2000","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/11046063","citation_count":134,"is_preprint":false},{"pmid":"12626541","id":"PMC_12626541","title":"Role of the cytoplasmic tails of CXCR1 and CXCR2 in mediating leukocyte migration, activation, and regulation.","date":"2003","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/12626541","citation_count":120,"is_preprint":false},{"pmid":"19683430","id":"PMC_19683430","title":"Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression.","date":"2009","source":"European journal of cancer (Oxford, England : 1990)","url":"https://pubmed.ncbi.nlm.nih.gov/19683430","citation_count":120,"is_preprint":false},{"pmid":"21035946","id":"PMC_21035946","title":"Small molecule antagonists for CXCR2 and CXCR1 inhibit human colon cancer liver metastases.","date":"2010","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/21035946","citation_count":118,"is_preprint":false},{"pmid":"11553670","id":"PMC_11553670","title":"The chemokine interleukin-8 acutely reduces Ca(2+) currents in identified cholinergic septal neurons expressing CXCR1 and CXCR2 receptor mRNAs.","date":"2001","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11553670","citation_count":116,"is_preprint":false},{"pmid":"15028716","id":"PMC_15028716","title":"On the mechanism and significance of ligand-induced internalization of human neutrophil chemokine receptors CXCR1 and CXCR2.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15028716","citation_count":109,"is_preprint":false},{"pmid":"10347185","id":"PMC_10347185","title":"beta-arrestins regulate interleukin-8-induced CXCR1 internalization.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10347185","citation_count":106,"is_preprint":false},{"pmid":"17496166","id":"PMC_17496166","title":"Pharmacological characterization of Sch527123, a potent allosteric CXCR1/CXCR2 antagonist.","date":"2007","source":"The Journal of pharmacology and experimental therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/17496166","citation_count":102,"is_preprint":false},{"pmid":"35011369","id":"PMC_35011369","title":"Roles of the CXCL8-CXCR1/2 Axis in the Tumor Microenvironment and Immunotherapy.","date":"2021","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/35011369","citation_count":96,"is_preprint":false},{"pmid":"19401689","id":"PMC_19401689","title":"CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion.","date":"2009","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/19401689","citation_count":95,"is_preprint":false},{"pmid":"15133028","id":"PMC_15133028","title":"Ligand selectivity and affinity of chemokine receptor CXCR1. Role of N-terminal domain.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15133028","citation_count":94,"is_preprint":false},{"pmid":"34353854","id":"PMC_34353854","title":"Combined Inhibition of SHP2 and CXCR1/2 Promotes Antitumor T-cell Response in NSCLC.","date":"2021","source":"Cancer discovery","url":"https://pubmed.ncbi.nlm.nih.gov/34353854","citation_count":92,"is_preprint":false},{"pmid":"36585453","id":"PMC_36585453","title":"Targeting T cell checkpoints 41BB and LAG3 and myeloid cell CXCR1/CXCR2 results in antitumor immunity and durable response in pancreatic cancer.","date":"2022","source":"Nature cancer","url":"https://pubmed.ncbi.nlm.nih.gov/36585453","citation_count":87,"is_preprint":false},{"pmid":"9712063","id":"PMC_9712063","title":"CXCR1 and CXCR2 are rapidly down-modulated by bacterial endotoxin through a unique agonist-independent, tyrosine kinase-dependent mechanism.","date":"1998","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/9712063","citation_count":87,"is_preprint":false},{"pmid":"15974585","id":"PMC_15974585","title":"2-Arylpropionic CXC chemokine receptor 1 (CXCR1) ligands as novel noncompetitive CXCL8 inhibitors.","date":"2005","source":"Journal of medicinal chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15974585","citation_count":85,"is_preprint":false},{"pmid":"24335961","id":"PMC_24335961","title":"The CXCL7/CXCR1/2 axis is a key driver in the growth of clear cell renal cell carcinoma.","date":"2013","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/24335961","citation_count":83,"is_preprint":false},{"pmid":"34893315","id":"PMC_34893315","title":"Reduction of NETosis by targeting CXCR1/2 reduces thrombosis, lung injury, and mortality in experimental human and murine sepsis.","date":"2021","source":"British journal of anaesthesia","url":"https://pubmed.ncbi.nlm.nih.gov/34893315","citation_count":82,"is_preprint":false},{"pmid":"30086759","id":"PMC_30086759","title":"IL-8/CXCR1/2 signalling promotes tumor cell proliferation, invasion and vascular mimicry in glioblastoma.","date":"2018","source":"Journal of biomedical science","url":"https://pubmed.ncbi.nlm.nih.gov/30086759","citation_count":82,"is_preprint":false},{"pmid":"11356265","id":"PMC_11356265","title":"Expression of the chemokine receptors CXCR1 and CXCR2 in rat oligodendroglial cells.","date":"2001","source":"Brain research. Developmental brain research","url":"https://pubmed.ncbi.nlm.nih.gov/11356265","citation_count":78,"is_preprint":false},{"pmid":"25315007","id":"PMC_25315007","title":"CXCR1/2 inhibition blocks and reverses type 1 diabetes in mice.","date":"2014","source":"Diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/25315007","citation_count":76,"is_preprint":false},{"pmid":"10623425","id":"PMC_10623425","title":"Differential modes of regulation of cxc chemokine-induced internalization and recycling of human CXCR1 and CXCR2.","date":"1999","source":"Cytokine","url":"https://pubmed.ncbi.nlm.nih.gov/10623425","citation_count":74,"is_preprint":false},{"pmid":"26791948","id":"PMC_26791948","title":"CXCR1-mediated neutrophil degranulation and fungal killing promote Candida clearance and host survival.","date":"2016","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26791948","citation_count":72,"is_preprint":false},{"pmid":"15294933","id":"PMC_15294933","title":"Cutting edge: expression of chemokine receptor CXCR1 on human effector CD8+ T cells.","date":"2004","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/15294933","citation_count":71,"is_preprint":false},{"pmid":"23132735","id":"PMC_23132735","title":"Neutrophils recruited by CXCR1/2 signalling mediate post-incisional pain.","date":"2012","source":"European journal of pain (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/23132735","citation_count":70,"is_preprint":false},{"pmid":"32188703","id":"PMC_32188703","title":"Simultaneous inhibition of CXCR1/2, TGF-β, and PD-L1 remodels the tumor and its microenvironment to drive antitumor immunity.","date":"2020","source":"Journal for immunotherapy of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32188703","citation_count":69,"is_preprint":false},{"pmid":"21718305","id":"PMC_21718305","title":"Receptor binding mode and pharmacological characterization of a potent and selective dual CXCR1/CXCR2 non-competitive allosteric inhibitor.","date":"2012","source":"British journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/21718305","citation_count":64,"is_preprint":false},{"pmid":"15252057","id":"PMC_15252057","title":"Dimer dissociation is essential for interleukin-8 (IL-8) binding to CXCR1 receptor.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15252057","citation_count":64,"is_preprint":false},{"pmid":"26517518","id":"PMC_26517518","title":"Targeting CXCR1 on breast cancer stem cells: signaling pathways and clinical application modelling.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26517518","citation_count":62,"is_preprint":false},{"pmid":"18826477","id":"PMC_18826477","title":"TLR- and CXCR1-dependent innate immunity: insights into the genetics of urinary tract infections.","date":"2008","source":"European journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/18826477","citation_count":61,"is_preprint":false},{"pmid":"20044480","id":"PMC_20044480","title":"The cytomegalovirus UL146 gene product vCXCL1 targets both CXCR1 and CXCR2 as an agonist.","date":"2009","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20044480","citation_count":60,"is_preprint":false},{"pmid":"10734056","id":"PMC_10734056","title":"Regulation of the human chemokine receptor CCR1. Cross-regulation by CXCR1 and CXCR2.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10734056","citation_count":55,"is_preprint":false},{"pmid":"16084593","id":"PMC_16084593","title":"A homolog of the human chemokine receptor CXCR1 is expressed in the mouse.","date":"2005","source":"Molecular immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16084593","citation_count":54,"is_preprint":false},{"pmid":"27557518","id":"PMC_27557518","title":"IL-8 promotes HNSCC progression on CXCR1/2-meidated NOD1/RIP2 signaling pathway.","date":"2016","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27557518","citation_count":53,"is_preprint":false},{"pmid":"15967374","id":"PMC_15967374","title":"Cloning and characterization of mouse homolog of the CXC chemokine receptor CXCR1.","date":"2005","source":"Cytokine","url":"https://pubmed.ncbi.nlm.nih.gov/15967374","citation_count":53,"is_preprint":false},{"pmid":"26087179","id":"PMC_26087179","title":"CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26087179","citation_count":52,"is_preprint":false},{"pmid":"30185911","id":"PMC_30185911","title":"Cxcr1 mediates recruitment of neutrophils and supports proliferation of tumor-initiating astrocytes in vivo.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/30185911","citation_count":52,"is_preprint":false},{"pmid":"15579377","id":"PMC_15579377","title":"CXCL8 modulates human intestinal epithelial cells through a CXCR1 dependent pathway.","date":"2005","source":"Cytokine","url":"https://pubmed.ncbi.nlm.nih.gov/15579377","citation_count":51,"is_preprint":false},{"pmid":"20230195","id":"PMC_20230195","title":"Targeting CXCR1/CXCR2 receptor antagonism in malignant melanoma.","date":"2010","source":"Expert opinion on therapeutic targets","url":"https://pubmed.ncbi.nlm.nih.gov/20230195","citation_count":49,"is_preprint":false},{"pmid":"35908611","id":"PMC_35908611","title":"Targeting CXCR1 and CXCR2 receptors in cardiovascular diseases.","date":"2022","source":"Pharmacology & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/35908611","citation_count":47,"is_preprint":false},{"pmid":"34097917","id":"PMC_34097917","title":"The IL-8-CXCR1/2 axis contributes to diabetic kidney disease.","date":"2021","source":"Metabolism: clinical and experimental","url":"https://pubmed.ncbi.nlm.nih.gov/34097917","citation_count":45,"is_preprint":false},{"pmid":"20089160","id":"PMC_20089160","title":"CXCR1 and SLC11A1 polymorphisms affect susceptibility to cutaneous leishmaniasis in Brazil: a case-control and family-based study.","date":"2010","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20089160","citation_count":44,"is_preprint":false},{"pmid":"37249756","id":"PMC_37249756","title":"Therapeutic inhibition of CXCR1/2: where do we stand?","date":"2023","source":"Internal and emergency medicine","url":"https://pubmed.ncbi.nlm.nih.gov/37249756","citation_count":43,"is_preprint":false},{"pmid":"19890050","id":"PMC_19890050","title":"Dynamic regulation of CXCR1 and CXCR2 homo- and heterodimers.","date":"2009","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/19890050","citation_count":43,"is_preprint":false},{"pmid":"35589610","id":"PMC_35589610","title":"Ladarixin, an inhibitor of the interleukin-8 receptors CXCR1 and CXCR2, in new-onset type 1 diabetes: A multicentre, randomized, double-blind, placebo-controlled trial.","date":"2022","source":"Diabetes, obesity & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/35589610","citation_count":43,"is_preprint":false},{"pmid":"28351983","id":"PMC_28351983","title":"CXCR1 remodels the vascular niche to promote hematopoietic stem and progenitor cell engraftment.","date":"2017","source":"The Journal of experimental medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28351983","citation_count":42,"is_preprint":false},{"pmid":"34426905","id":"PMC_34426905","title":"An updated review on the role of the CXCL8-CXCR1/2 axis in the progression and metastasis of breast cancer.","date":"2021","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/34426905","citation_count":42,"is_preprint":false},{"pmid":"30984000","id":"PMC_30984000","title":"Activation of CXCL6/CXCR1/2 Axis Promotes the Growth and Metastasis of Osteosarcoma Cells in vitro and in vivo.","date":"2019","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30984000","citation_count":41,"is_preprint":false},{"pmid":"16541017","id":"PMC_16541017","title":"Expression of the chemokine receptor CXCR1 in human glomerular diseases.","date":"2006","source":"Kidney international","url":"https://pubmed.ncbi.nlm.nih.gov/16541017","citation_count":37,"is_preprint":false},{"pmid":"12239185","id":"PMC_12239185","title":"Phagocytosing neutrophils down-regulate the expression of chemokine receptors CXCR1 and CXCR2.","date":"2002","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/12239185","citation_count":37,"is_preprint":false},{"pmid":"11531949","id":"PMC_11531949","title":"Down-regulation of CXCR1 and CXCR2 expression on human neutrophils upon activation of whole blood by S. aureus is mediated by TNF-alpha.","date":"2001","source":"Clinical and experimental immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11531949","citation_count":37,"is_preprint":false},{"pmid":"31516616","id":"PMC_31516616","title":"Interleukin-8 promotes cell migration via CXCR1 and CXCR2 in liver cancer.","date":"2019","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/31516616","citation_count":36,"is_preprint":false},{"pmid":"32391006","id":"PMC_32391006","title":"Structural Insights Into How Proteoglycans Determine Chemokine-CXCR1/CXCR2 Interactions: Progress and Challenges.","date":"2020","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32391006","citation_count":35,"is_preprint":false},{"pmid":"25031742","id":"PMC_25031742","title":"High expression of GPER1, EGFR and CXCR1 is associated with lymph node metastasis in papillary thyroid carcinoma.","date":"2014","source":"International journal of clinical and experimental pathology","url":"https://pubmed.ncbi.nlm.nih.gov/25031742","citation_count":35,"is_preprint":false},{"pmid":"24965032","id":"PMC_24965032","title":"The chemokine receptors CXCR1 and CXCR2 regulate oral cancer cell behaviour.","date":"2014","source":"Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology","url":"https://pubmed.ncbi.nlm.nih.gov/24965032","citation_count":34,"is_preprint":false},{"pmid":"30797069","id":"PMC_30797069","title":"Sinomenine inhibits osteolysis in breast cancer by reducing IL-8/CXCR1 and c-Fos/NFATc1 signaling.","date":"2019","source":"Pharmacological research","url":"https://pubmed.ncbi.nlm.nih.gov/30797069","citation_count":34,"is_preprint":false},{"pmid":"30738331","id":"PMC_30738331","title":"Disrupting Inflammation-Associated CXCL8-CXCR1 Signaling Inhibits Tumorigenicity Initiated by Sporadic- and Colitis-Colon Cancer Stem Cells.","date":"2019","source":"Neoplasia (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/30738331","citation_count":33,"is_preprint":false},{"pmid":"21036625","id":"PMC_21036625","title":"CXCR1 and CXCR2 are novel mechano-sensors mediating laminar shear stress-induced endothelial cell migration.","date":"2010","source":"Cytokine","url":"https://pubmed.ncbi.nlm.nih.gov/21036625","citation_count":32,"is_preprint":false},{"pmid":"16339057","id":"PMC_16339057","title":"Expression of interleukin-8 receptors (CXCR1 and CXCR2) in premenopausal women with recurrent urinary tract infections.","date":"2005","source":"Clinical and diagnostic laboratory immunology","url":"https://pubmed.ncbi.nlm.nih.gov/16339057","citation_count":32,"is_preprint":false},{"pmid":"26473526","id":"PMC_26473526","title":"Combined inhibition of IL1, CXCR1/2, and TGFβ signaling pathways modulates in-vivo resistance to anti-VEGF treatment.","date":"2016","source":"Anti-cancer drugs","url":"https://pubmed.ncbi.nlm.nih.gov/26473526","citation_count":32,"is_preprint":false},{"pmid":"11465111","id":"PMC_11465111","title":"Immunobiology of CD28 expression on human neutrophils. I. CD28 regulates neutrophil migration by modulating CXCR-1 expression.","date":"2001","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11465111","citation_count":32,"is_preprint":false},{"pmid":"32800946","id":"PMC_32800946","title":"KLF2 regulates neutrophil migration by modulating CXCR1 and CXCR2 in asthma.","date":"2020","source":"Biochimica et biophysica acta. Molecular basis of disease","url":"https://pubmed.ncbi.nlm.nih.gov/32800946","citation_count":31,"is_preprint":false},{"pmid":"22024025","id":"PMC_22024025","title":"Optimization of purification and refolding of the human chemokine receptor CXCR1 improves the stability of proteoliposomes for structure determination.","date":"2011","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/22024025","citation_count":31,"is_preprint":false},{"pmid":"27551720","id":"PMC_27551720","title":"Chemokine Receptors, CXCR1 and CXCR2, Differentially Regulate Exosome Release in Hepatocytes.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27551720","citation_count":29,"is_preprint":false},{"pmid":"11688722","id":"PMC_11688722","title":"Signal transduction by the chemokine receptor CXCR5: structural requirements for G protein activation analyzed by chimeric CXCR1/CXCR5 molecules.","date":"2001","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11688722","citation_count":28,"is_preprint":false},{"pmid":"26275440","id":"PMC_26275440","title":"The CXCR1/2 Pathway: Involvement in Diabetes Pathophysiology and Potential Target for T1D Interventions.","date":"2015","source":"Current diabetes reports","url":"https://pubmed.ncbi.nlm.nih.gov/26275440","citation_count":26,"is_preprint":false},{"pmid":"27966653","id":"PMC_27966653","title":"The accessory proteins REEP5 and REEP6 refine CXCR1-mediated cellular responses and lung cancer progression.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27966653","citation_count":26,"is_preprint":false},{"pmid":"37062329","id":"PMC_37062329","title":"Small molecule antagonist of CXCR2 and CXCR1 inhibits tumor growth, angiogenesis, and metastasis in pancreatic cancer.","date":"2023","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/37062329","citation_count":25,"is_preprint":false},{"pmid":"30123110","id":"PMC_30123110","title":"Role of CXCR1 and Interleukin-8 in Methamphetamine-Induced Neuronal Apoptosis.","date":"2018","source":"Frontiers in cellular neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/30123110","citation_count":25,"is_preprint":false},{"pmid":"15557597","id":"PMC_15557597","title":"Downregulation of CXCR1 and CXCR2 expression on human neutrophils by Helicobacter pylori: a new pathomechanism in H. pylori infection?","date":"2004","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/15557597","citation_count":25,"is_preprint":false},{"pmid":"20877331","id":"PMC_20877331","title":"Inhibition of CXCR1 and CXCR2 chemokine receptors attenuates acute inflammation, preserves gray matter and diminishes autonomic dysreflexia after spinal cord injury.","date":"2010","source":"Spinal cord","url":"https://pubmed.ncbi.nlm.nih.gov/20877331","citation_count":25,"is_preprint":false},{"pmid":"37760523","id":"PMC_37760523","title":"The Role of CXCR1, CXCR2, CXCR3, CXCR5, and CXCR6 Ligands in Molecular Cancer Processes and Clinical Aspects of Acute Myeloid Leukemia (AML).","date":"2023","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/37760523","citation_count":24,"is_preprint":false},{"pmid":"22325052","id":"PMC_22325052","title":"Genetic variations of interleukin-8, CXCR1 and CXCR2 genes and risk of acute pyelonephritis in children.","date":"2012","source":"International journal of immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/22325052","citation_count":23,"is_preprint":false},{"pmid":"34014914","id":"PMC_34014914","title":"Conformational plasticity and dynamic interactions of the N-terminal domain of the chemokine receptor CXCR1.","date":"2021","source":"PLoS computational biology","url":"https://pubmed.ncbi.nlm.nih.gov/34014914","citation_count":22,"is_preprint":false},{"pmid":"12065915","id":"PMC_12065915","title":"Expression of the interleukin-8 receptors CXCR1 and CXCR2 on cord-blood-derived cultured human mast cells.","date":"2002","source":"International archives of allergy and immunology","url":"https://pubmed.ncbi.nlm.nih.gov/12065915","citation_count":21,"is_preprint":false},{"pmid":"16081690","id":"PMC_16081690","title":"Human CD8+ T cells store CXCR1 in a distinct intracellular compartment and up-regulate it rapidly to the cell surface upon activation.","date":"2005","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/16081690","citation_count":21,"is_preprint":false},{"pmid":"31573846","id":"PMC_31573846","title":"The antagonist of CXCR1 and CXCR2 protects db/db mice from metabolic diseases through modulating inflammation.","date":"2019","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/31573846","citation_count":20,"is_preprint":false},{"pmid":"33858417","id":"PMC_33858417","title":"MiR-126, IL-7, CXCR1/2 receptors, inflammation and circulating endothelial progenitor cells: The study on targets for treatment pathways in a model of subclinical cardiovascular disease (type 1 diabetes mellitus).","date":"2021","source":"Journal of translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33858417","citation_count":20,"is_preprint":false},{"pmid":"32052443","id":"PMC_32052443","title":"MMP9, CXCR1, TLR6, and MPO participant in the progression of coronary artery disease.","date":"2020","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/32052443","citation_count":19,"is_preprint":false},{"pmid":"17360650","id":"PMC_17360650","title":"A haplotype of the human CXCR1 gene protective against rapid disease progression in HIV-1+ patients.","date":"2007","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/17360650","citation_count":19,"is_preprint":false},{"pmid":"26983663","id":"PMC_26983663","title":"CXCR1 promotes malignant behavior of gastric cancer cells in vitro and in vivo in AKT and ERK1/2 phosphorylation.","date":"2016","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/26983663","citation_count":19,"is_preprint":false},{"pmid":"20226759","id":"PMC_20226759","title":"Membrane interaction of the N-terminal domain of chemokine receptor CXCR1.","date":"2010","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/20226759","citation_count":19,"is_preprint":false},{"pmid":"10653603","id":"PMC_10653603","title":"Downregulation of CXCR-2 but not CXCR-1 expression by human keratinocytes by UVB.","date":"2000","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/10653603","citation_count":19,"is_preprint":false},{"pmid":"36325326","id":"PMC_36325326","title":"CXCR1 and its downstream NF-κB inflammation signaling pathway as a key target of Guanxinning injection for myocardial ischemia/reperfusion injury.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36325326","citation_count":18,"is_preprint":false},{"pmid":"34120407","id":"PMC_34120407","title":"MiR-144-induced KLF2 inhibition and NF-kappaB/CXCR1 activation promote neutrophil extracellular trap-induced transfusion-related acute lung injury.","date":"2021","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34120407","citation_count":18,"is_preprint":false},{"pmid":"21915051","id":"PMC_21915051","title":"Elevated expression of the interleukin-8 receptors CXCR1 and CXCR2 in peripheral blood cells in obstructive coronary artery disease.","date":"2011","source":"Coronary artery disease","url":"https://pubmed.ncbi.nlm.nih.gov/21915051","citation_count":18,"is_preprint":false},{"pmid":"25834784","id":"PMC_25834784","title":"Characterization of G protein coupling mediated by the conserved D134(3.49) of DRY motif, M241(6.34), and F251(6.44) residues on human CXCR1.","date":"2015","source":"FEBS open bio","url":"https://pubmed.ncbi.nlm.nih.gov/25834784","citation_count":18,"is_preprint":false},{"pmid":"37709757","id":"PMC_37709757","title":"CXCR1 drives the pathogenesis of EAE and ARDS via boosting dendritic cells-dependent inflammation.","date":"2023","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/37709757","citation_count":17,"is_preprint":false},{"pmid":"18006311","id":"PMC_18006311","title":"3,4-Diamino-2,5-thiadiazole-1-oxides as potent CXCR2/CXCR1 antagonists.","date":"2007","source":"Bioorganic & medicinal chemistry letters","url":"https://pubmed.ncbi.nlm.nih.gov/18006311","citation_count":17,"is_preprint":false},{"pmid":"17026468","id":"PMC_17026468","title":"IFN gamma and CXCR-1 gene polymorphisms in idiopathic bronchiectasis.","date":"2006","source":"Tissue antigens","url":"https://pubmed.ncbi.nlm.nih.gov/17026468","citation_count":17,"is_preprint":false},{"pmid":"30486423","id":"PMC_30486423","title":"Differential Effects of Posttranslational Modifications of CXCL8/Interleukin-8 on CXCR1 and CXCR2 Internalization and Signaling Properties.","date":"2018","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/30486423","citation_count":17,"is_preprint":false},{"pmid":"28869519","id":"PMC_28869519","title":"Differences in Sulfotyrosine Binding amongst CXCR1 and CXCR2 Chemokine Ligands.","date":"2017","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/28869519","citation_count":17,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":54903,"output_tokens":9253,"usd":0.151752},"stage2":{"model":"claude-opus-4-6","input_tokens":13169,"output_tokens":4943,"usd":0.28413},"total_usd":0.435882,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1999,\n      \"finding\": \"β-arrestins regulate IL-8-induced CXCR1 internalization: GRK2 and β-arrestin proteins are required for CXCR1 internalization in HEK 293 cells; a dominant-negative β-arrestin 1-V53D mutant blocks CXCR1 internalization; dynamin is also required; internalization occurs via clathrin-coated vesicles.\",\n      \"method\": \"CXCR1-GFP constructs transiently expressed in HEK 293 and RBL-2H3 cells; dominant-negative mutants (β-arrestin 1-V53D, dynamin I-K44A); co-localization with transferrin in endosomes\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal dominant-negative mutant experiments with multiple orthogonal approaches in two cell lines\",\n      \"pmids\": [\"10347185\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"IL-8-induced internalization of CXCR1 is profoundly dependent on a carboxyl-terminal region containing six phosphorylation sites, whereas CXCR2 internalization is primarily regulated by a membrane-proximal domain that lacks phosphorylation sites; both receptors recycle after ligand removal.\",\n      \"method\": \"HEK 293 cell transfectants expressing wild-type and carboxyl-tail mutants of CXCR1 and CXCR2; receptor internalization and recycling assays\",\n      \"journal\": \"Cytokine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct comparison of phosphorylation-site mutants between CXCR1 and CXCR2 with multiple functional readouts\",\n      \"pmids\": [\"10623425\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"LPS down-modulates CXCR1 and CXCR2 expression on neutrophils through an agonist-independent, tyrosine kinase-dependent pathway involving p72syk hyperphosphorylation; tyrosine kinase inhibitors (genistein, herbimycin A) attenuate this down-modulation, whereas they have no effect on IL-8-induced receptor down-modulation.\",\n      \"method\": \"Flow cytometry of CXCR1/CXCR2 on human neutrophils; tyrosine kinase inhibitor experiments; ELISA for cytokines; western blot for p72syk phosphorylation\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological inhibitor experiments with mechanistic follow-up (p72syk phosphorylation) and appropriate controls\",\n      \"pmids\": [\"9712063\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Phosphorylation of the C-tails of CXCR1 and CXCR2 is required for β-arrestin translocation and receptor internalization; C-tail-deleted and phosphorylation-deficient mutants show greater phosphoinositide hydrolysis and exocytosis but diminished chemotaxis; receptor internalization is not required for chemotaxis. CXCR2 (but not CXCR1) undergoes rapid internalization that is not fully explained by C-tail phosphorylation alone.\",\n      \"method\": \"Wild-type, chimeric, phosphorylation-deficient, and C-tail deletion mutants of CXCR1/CXCR2 expressed in RBL-2H3 cells; receptor phosphorylation, desensitization, internalization, β-arrestin 2 translocation, and chemotaxis assays\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple mutant constructs with comprehensive functional readouts in a well-controlled system\",\n      \"pmids\": [\"12626541\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"CXCR1 ligand selectivity is mediated by its N-terminal domain (N-domain): IL-8 binds the N-domain with higher affinity in membrane-mimicking micelles (~1 µM) than in solution (~20 µM); MGSA does not bind the N-domain in solution but binds in micelles (~3 µM); the entire N-domain interacts with the micelle in an extended fashion, with conformational restraint governing ligand-binding properties.\",\n      \"method\": \"NMR structural studies; ligand-binding in detergent micelles vs. solution; fluorescence and circular dichroism spectroscopy\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — NMR structural characterization with quantitative binding measurements in physiological membrane-mimicking environment\",\n      \"pmids\": [\"15133028\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Only the IL-8 monomer (not the dimer) is competent to bind the CXCR1 N-terminal domain; IL-8 dimerization functions as a negative regulator for receptor binding and a positive regulator for glycosaminoglycan binding.\",\n      \"method\": \"Isothermal titration calorimetry and sedimentation equilibrium to measure IL-8 binding to the CXCR1 N-domain; comparison of native IL-8 vs. monomer/dimer\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — quantitative biophysical methods (ITC + sedimentation equilibrium) directly measuring binding with mechanistic interpretation\",\n      \"pmids\": [\"15252057\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Ligand-induced endocytosis of CXCR1 and CXCR2 in primary human neutrophils requires ~10-fold higher agonist concentrations than maximal chemotaxis and calcium flux; both receptors are excluded from Triton X-100-insoluble lipid rafts and internalized via a clathrin/rab5/dynamin-dependent pathway; receptor endocytosis is not required for chemotaxis.\",\n      \"method\": \"Primary human neutrophil receptor internalization assays; calcium flux measurements; sucrose density gradient fractionation (lipid raft analysis); clathrin/dynamin pathway inhibitor experiments\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in primary human neutrophils with rigorous concentration-response analyses\",\n      \"pmids\": [\"15028716\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Repertaxin (reparixin) acts as a noncompetitive CXCL8 inhibitor by interacting with a putative binding site in the transmembrane region of CXCR1; the binding model was confirmed by alanine scanning mutagenesis and photoaffinity labeling experiments.\",\n      \"method\": \"Molecular modeling; alanine scanning mutagenesis of CXCR1; photoaffinity labeling experiments\",\n      \"journal\": \"Journal of medicinal chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis combined with photoaffinity labeling providing direct evidence for binding site\",\n      \"pmids\": [\"15974585\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Murine CXCR1 (mCXCR1) is a functional receptor predominantly engaged by mouse GCP-2/CXCL6, human GCP-2, and IL-8/CXCL8, but not by CXCR2 ligands (ENA-78, NAP-2, GRO-α/β/γ); functional characterization via binding, GTPγS exchange stimulation, and chemotaxis of mCXCR1-transfected cells.\",\n      \"method\": \"Radioligand binding; GTPγS exchange assay; chemotaxis assay with transfected cells; RT-PCR for tissue distribution\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution with multiple in vitro functional assays establishing ligand selectivity\",\n      \"pmids\": [\"17197447\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"IL-8 promotes bacterial killing by neutrophils through CXCR1 but not CXCR2; proteolytic cleavage of CXCR1 on neutrophils in cystic fibrosis airways disables their bacterial-killing capacity; soluble glycosylated CXCR1 fragments stimulate IL-8 production in bronchial epithelial cells via TLR2; in vivo inhalation of α1-antitrypsin restored CXCR1 expression and bacterial killing.\",\n      \"method\": \"Protease treatment of neutrophils; functional bacterial killing assays; CXCR1 fragment identification and TLR2 stimulation assays; in vivo α1-antitrypsin inhalation study in CF patients\",\n      \"journal\": \"Nature medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (in vitro functional assays, receptor fragment characterization, in vivo rescue) replicated across human and in vitro models\",\n      \"pmids\": [\"18059279\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"SCH527123 (Sch527123) is an allosteric antagonist of both CXCR1 and CXCR2, acting in an insurmountable (non-competitive) manner; it binds CXCR1 with Kd = 3.9 nM and CXCR2 with Kd = 0.049 nM; it inhibits CXCL1- and CXCL8-stimulated neutrophil chemotaxis and myeloperoxidase release without affecting C5a or fMLP responses.\",\n      \"method\": \"Radioligand binding ([³H]Sch527123); equilibrium and non-equilibrium binding analyses; GTPγS binding; neutrophil chemotaxis and MPO release assays; receptor selectivity panel\",\n      \"journal\": \"The Journal of pharmacology and experimental therapeutics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — quantitative binding characterization combined with functional assays establishing allosteric mechanism\",\n      \"pmids\": [\"17496166\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CXCR1 and CXCR2 form homo- and heterodimers in human neutrophils and cell lines; CXCL8 alters heterodimeric complexes while stabilizing homodimers and promoting receptor internalization; receptor expression level and ligand activation regulate the balance between these oligomeric states.\",\n      \"method\": \"Fluorescence resonance energy transfer (FRET) in human neutrophils and transfected cell lines; receptor expression modulation experiments\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — FRET-based direct measurement of receptor dimerization in primary human neutrophils and cell lines with multiple conditions\",\n      \"pmids\": [\"19890050\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"CMV UL146 gene product vCXCL1 acts as an agonist on both CXCR1 and CXCR2 (Kd = 44 nM and 5.6 nM, respectively), inducing calcium mobilization, phosphatidylinositol turnover, and chemotaxis via these receptors, but does not activate or block any other 16 human chemokine receptors.\",\n      \"method\": \"Competition binding against radiolabeled CXCL8; calcium mobilization assays; inositol triphosphate turnover; chemotaxis assays in CXCR1/CXCR2-expressing CHO, 300.19, COS7, and L1.2 cells\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted functional assays with quantitative binding across full receptor panel\",\n      \"pmids\": [\"20044480\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"CXCR1 blockade in breast cancer stem cells (CSCs) depletes the CSC population and induces massive apoptosis in the bulk tumor via FASL/FAS signaling; these effects are mediated by the FAK/AKT/FOXO3A pathway.\",\n      \"method\": \"CXCR1-specific blocking antibody and repertaxin (small-molecule inhibitor); in vitro CSC depletion assays; apoptosis assays; pathway inhibitor studies (FAK/AKT/FOXO3A); human breast cancer xenografts in mice\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (antibody + small molecule, in vitro + in vivo) with defined pathway placement\",\n      \"pmids\": [\"20051626\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"DF 2156A, a dual CXCR1/CXCR2 inhibitor, acts as a non-competitive allosteric inhibitor; polar interactions stabilized by a direct ionic bond between DF 2156A and Lys99 on CXCR1 (and non-conserved Asp293 on CXCR2) are key determinants of binding; it blocks signal transduction leading to chemotaxis without altering natural ligand binding affinity.\",\n      \"method\": \"Radioligand and [³⁵S]-GTPγS binding; chemotaxis of L1.2 transfectants and human leukocytes; murine models of angiogenesis and liver ischemia/reperfusion; molecular characterization of binding mode\",\n      \"journal\": \"British journal of pharmacology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — site-specific binding characterization (ionic bond to Lys99) combined with functional assays and in vivo validation\",\n      \"pmids\": [\"21718305\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Staphylococcus aureus LukED toxin targets CXCR1 and CXCR2 on neutrophils; the LukE subunit binds neutrophils in a specific and saturable manner, and this binding is inhibited by CXCL8 (the high-affinity endogenous ligand); CXCR1/2 targeting by LukED promotes killing of monocytes and neutrophils in vitro and facilitates lethality in bacteremic mice.\",\n      \"method\": \"Saturation binding assays; CXCL8 competition binding; in vitro cytotoxicity assays with CXCR1/2-expressing cells; murine systemic infection model with LukED-deficient bacteria\",\n      \"journal\": \"Cell host & microbe\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — saturable and competitive binding assays in primary cells combined with in vivo genetic validation\",\n      \"pmids\": [\"24139401\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"CXCR1-mediated neutrophil degranulation (not chemotaxis) is critical for fungal killing; Cxcr1-/- mice show decreased survival and enhanced Candida growth in the kidney due to a cell-intrinsic defect in neutrophil degranulation; the human mutant CXCR1-T276 allele also results in impaired neutrophil degranulation and fungal killing.\",\n      \"method\": \"Cxcr1-/- mouse generation; systemic candidiasis model; neutrophil trafficking and degranulation assays; human CXCR1-T276 variant functional studies; patient genetic association\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — knockout mouse model with defined cellular phenotype (degranulation) confirmed in human variant, replicated across mouse and human\",\n      \"pmids\": [\"26791948\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"CXCR1 couples to G proteins through its DRY motif: D134(3.49) mutations (D134N, D134V) completely abolish ligand binding and functional response of CXCR1; point mutations M241(6.34) and F251(6.44) on TM6 generate mutant receptors with modest constitutive activity via Gα15 signaling, identifying a 'hot spot' for CXCR1 activation.\",\n      \"method\": \"Alanine/point mutagenesis of CXCR1; radioligand binding; calcium mobilization assays; G protein activation (Gα15) assays in transfected cells\",\n      \"journal\": \"FEBS open bio\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — site-directed mutagenesis with multiple functional readouts establishing catalytic/coupling mechanism\",\n      \"pmids\": [\"25834784\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"IL-8 stimulation of CXCR1 or CXCR2 cross-phosphorylates CCR1 and cross-desensitizes its ability to stimulate GTPase activity and Ca2+ mobilization; CCR1 cross-phosphorylates and cross-desensitizes CXCR2 but not CXCR1, revealing selective asymmetric cross-regulation among chemokine receptors.\",\n      \"method\": \"RBL-2H3 cells co-expressing CCR1 with CXCR1, CXCR2, or phosphorylation-deficient CXCR2-331T; receptor phosphorylation, GTPase stimulation, Ca2+ mobilization, and internalization assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple phosphorylation and functional assays in co-expressing cells with mechanistic mutant controls\",\n      \"pmids\": [\"10734056\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"IL-8 acutely reduces Ca2+ currents in cholinergic septal neurons expressing CXCR1 and CXCR2 mRNAs via closure of L- and N-type Ca2+ channels and activation of Giα1 and/or Giα2 G-protein subtypes; this is the first report of CXCR1 mRNA expression in the brain and of a chemokine modulating ion channels in neurons via G-proteins.\",\n      \"method\": \"Whole-cell patch clamp recording; single-cell RT-PCR from recorded neurons; pharmacological G-protein dissection\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — electrophysiology with single-cell RT-PCR directly linking CXCR1 expression to functional ion channel modulation\",\n      \"pmids\": [\"11553670\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"CXCR1 (but not CXCR2) on uroepithelial cells mediates neutrophil transepithelial migration; anti-CXCR1 antibodies inhibit IL-8-dependent neutrophil migration across infected epithelial layers by ~60%; IL-8 receptor knockout mice fail to express the receptor on mucosal cells and cannot translocate neutrophils across the epithelial barrier.\",\n      \"method\": \"Antibody blocking of CXCR1 and CXCR2 in epithelial monolayer migration assays; IL-8 receptor knockout mouse model; experimental urinary tract infection model\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — receptor-specific antibody blockade in vitro confirmed by genetic knockout in vivo\",\n      \"pmids\": [\"11046063\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"CXCR1 and CXCR2 differentially regulate hepatocyte exosome release: CXCR1-deficient hepatocytes produce fewer exosomes and lack packaging of neutral ceramidase and sphingosine kinase enzymes required for exosome-mediated hepatocyte proliferation; CXCR2-deficient hepatocytes produce more exosomes via increased neutral sphingomyelinase activity and intracellular ceramide.\",\n      \"method\": \"CXCR1-/- and CXCR2-/- hepatocyte isolation; exosome quantification; neutral sphingomyelinase activity assays; enzyme content analysis of exosomes; hepatocyte proliferation assays\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — genetic knockout with mechanistic enzyme activity follow-up, single lab\",\n      \"pmids\": [\"27551720\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"REEP5 and REEP6 are accessory proteins that interact specifically with CXCR1 (but not CXCR2); they facilitate ligand-stimulated endocytosis of CXCR1 and intracellular clustering of β-arrestin2 after IL-8 treatment, rather than membrane expression of CXCR1; their depletion reduces CXCR1-mediated ERK phosphorylation, actin polymerization, and cancer cell invasion.\",\n      \"method\": \"Co-immunoprecipitation (CXCR1-REEP5/6 interaction); overexpression and siRNA knockdown; receptor internalization and β-arrestin2 clustering assays; ERK phosphorylation western blot; xenograft tumor model\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Co-IP plus functional rescue/knockdown experiments, single lab\",\n      \"pmids\": [\"27966653\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"CXCL8-CXCR1 signaling in astrocytes activates NF-κB to upregulate IL-8 expression; in neurons, CXCR1 mediates methamphetamine-induced apoptosis via astrocyte-released IL-8; siRNA knockdown of CXCR1 in SH-SY5Y neurons reduces cleaved caspase-3 and PARP expression, and this protection is reversed by recombinant IL-8.\",\n      \"method\": \"siRNA knockdown of CXCR1 in SH-SY5Y cells; co-culture of neurons and astrocytes; western blot for apoptosis markers (caspase-3, PARP); NF-κB pathway analysis; in vivo mouse METH model\",\n      \"journal\": \"Frontiers in cellular neuroscience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — siRNA knockdown with pathway rescue experiment, single lab\",\n      \"pmids\": [\"30123110\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Differential CXCL8 post-translational modifications (citrullination at position 5, N-terminal truncation to CXCL8(6-77)) enhance CXCR1 internalization and Gαi-dependent signaling; all CXCL8 variants promote β-arrestin 1 and 2 recruitment to CXCR1 and CXCR2; modifications do not alter the preference (bias) between Gαi-protein and β-arrestin signaling.\",\n      \"method\": \"Chemically synthesized native and modified CXCL8 variants; internalization assays in human neutrophils; Gαi signaling assays; β-arrestin 1/2 recruitment assays\",\n      \"journal\": \"International journal of molecular sciences\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — chemically defined ligand variants with multiple signaling readouts, single lab\",\n      \"pmids\": [\"30486423\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"CD28 cross-linking on human neutrophils causes early upregulation of CXCR1 surface expression and concurrent increase in IL-8-induced chemotaxis, followed by receptor internalization and reduced chemotaxis at 3 hours; this demonstrates CD28-mediated regulation of CXCR1 expression and neutrophil migration.\",\n      \"method\": \"CD28 cross-linking with anti-CD28 mAb; flow cytometry for CXCR1 expression; chemotaxis assays; immunoprecipitation\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — antibody cross-linking with functional migration readout, single lab\",\n      \"pmids\": [\"11465111\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Phagocytosis down-regulates CXCR1 and CXCR2 surface expression on neutrophils via metalloproteinase-dependent proteolytic degradation (not internalization); metalloproteinase inhibitor 1,10-phenanthroline prevents this reduction; down-regulation is accompanied by reduced Ca2+ responses to corresponding ligands.\",\n      \"method\": \"Phagocytosis of opsonized yeast; flow cytometry for CXCR1/CXCR2; metalloproteinase inhibitor (1,10-phenanthroline); confocal microscopy; Ca2+ response assays\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — pharmacological inhibitor plus confocal microscopy distinguishing proteolysis from internalization\",\n      \"pmids\": [\"12239185\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"TNF-α mediates S. aureus-induced down-regulation of CXCR1 and CXCR2 on neutrophils in whole blood; anti-TNF-α antibody abrogates this down-regulation; TNF-α-mediated decrease is associated with lower CXCR1/CXCR2 mRNA levels and is abrogated by protease inhibitors, indicating both transcriptional and proteolytic mechanisms.\",\n      \"method\": \"Whole blood stimulation with S. aureus; anti-TNF-α antibody blockade; flow cytometry; RT-PCR for mRNA; protease inhibitor experiments\",\n      \"journal\": \"Clinical and experimental immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — antibody neutralization with transcriptional and proteolytic mechanistic dissection, single lab\",\n      \"pmids\": [\"11531949\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"The CXCR1 N-terminal domain (34-mer peptide) interacts with phospholipid membranes (DOPC vesicles), causing motional restriction of tryptophan residues, increased fluorescence anisotropy, red edge excitation shift (REES) of 19 nm, and increased mean fluorescence lifetime; the entire N-domain interacts with the membrane in an extended fashion.\",\n      \"method\": \"Fluorescence spectroscopy (tryptophan emission, anisotropy, REES, lifetime); surface pressure measurements with DOPC vesicles\",\n      \"journal\": \"Biochimica et biophysica acta\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — quantitative biophysical characterization of N-domain membrane interaction, single lab\",\n      \"pmids\": [\"20226759\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Human CD8+ T cells store CXCR1 in a distinct intracellular compartment (partially co-localizing with Golgi marker GM130, early endosome marker EEA1, and constitutive secretory pathway marker β2-microglobulin, but not with perforin, RANTES, or lysosomal CD63) and rapidly up-regulate it to the cell surface within minutes of activation by neutrophil supernatants (not TCR cross-linking); CXCR1 up-regulation enables functional IL-8-directed migration.\",\n      \"method\": \"Immunofluorescence microscopy with organelle markers; flow cytometry; chemotaxis assay; kinetic surface expression assay\",\n      \"journal\": \"Blood\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct localization by immunofluorescence microscopy with defined functional consequence (chemotaxis), single lab\",\n      \"pmids\": [\"16081690\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"In zebrafish, cxcl8/cxcr1 signaling in endothelial cells positively regulates HSPC colonization of the caudal hematopoietic tissue (CHT) by increasing HSPC-endothelial cell 'cuddling', HSPC residency time, and mitotic rate; enhanced cxcr1 signaling induces an increase in CHT volume and cxcl12a expression; cxcr1 acts in a HSPC-nonautonomous manner to improve donor HSPC engraftment.\",\n      \"method\": \"Single-cell tracking (live imaging) of fluorescent HSPCs in zebrafish CHT; cxcr1 mutants; parabiotic zebrafish; pharmacological cxcr1 manipulation; measurement of HSPC-endothelial interactions\",\n      \"journal\": \"The Journal of experimental medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — live single-cell imaging with genetic mutant validation in zebrafish, single lab\",\n      \"pmids\": [\"28351983\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CXCR1 drives dendritic cell-mediated inflammation via a CXCL5/CXCR1/HIF-1α positive feedback loop that directly regulates IL-6/IL-12p70 production; DC-specific CXCR1 knockout reduces inflammatory cytokine production and ameliorates EAE disease severity and LPS-induced ARDS lung injury.\",\n      \"method\": \"Global and DC-specific CXCR1 knockout mice; EAE and LPS-induced ARDS models; cytokine profiling (IL-6, IL-12p70); mechanistic pathway analysis (HIF-1α); CXCL5 antibody neutralization\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — cell-type-specific knockout with defined positive feedback mechanism, single lab\",\n      \"pmids\": [\"37709757\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"The second intracellular domain of CXCR1 has a major influence on signaling via inhibitory G proteins; replacing the second intracellular domain of CXCR1 with that of CXCR5 strongly reduces ERK1/2-MAP kinase activation and chemotaxis despite retained Gi coupling; the third and C-terminal intracellular domains of CXCR5 have only minor effects on signal transduction.\",\n      \"method\": \"Chimeric CXCR1/CXCR5 receptor constructs; pertussis toxin sensitivity assays; Ca2+ signaling; ERK1/2 MAP kinase activation; chemotaxis assays\",\n      \"journal\": \"Biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — domain-swap mutagenesis with multiple signaling pathway readouts, single lab\",\n      \"pmids\": [\"11688722\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"IL-8 promotes HNSCC cell proliferation via CXCR1/2-mediated activation of the NOD1/RIP2 signaling pathway; IL-8 siRNA knockdown reduces CXCR1/2 expression and NOD1/RIP2 signaling; NOD1 and RIP2 expression is increased by IL-8 stimulation and reduced by IL-8 siRNA, while NOD2 shows an opposite pattern.\",\n      \"method\": \"siRNA knockdown of IL-8 and CXCR1/2 in HNSCC cell lines; proliferation and clonogenicity assays; western blot and RT-PCR for NOD1, NOD2, RIP2\",\n      \"journal\": \"Oncotarget\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — siRNA knockdown linking CXCR1/2 to NOD1/RIP2 pathway, single lab, limited mechanistic follow-up\",\n      \"pmids\": [\"27557518\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"CXCR1 promotes gastric cancer cell proliferation, migration, and invasion through AKT and ERK1/2 phosphorylation; CXCR1 knockdown reduces cyclin D1, EGFR, VEGF, MMP-9, MMP-2, and Bcl-2 while increasing Bax and E-cadherin; CXCR1 overexpression enhances tumor growth in vivo.\",\n      \"method\": \"Stable shRNA knockdown and overexpression in gastric cancer cell lines; MTT, colony formation, flow cytometry, transwell assays; western blot for signaling molecules; xenograft mouse model\",\n      \"journal\": \"International journal of oncology\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — stable KD/OE with signaling readouts, single lab, pathway placement inferred rather than directly established\",\n      \"pmids\": [\"26983663\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CXCR1 is a G protein-coupled chemokine receptor that binds IL-8/CXCL8 (and related ELR-CXC chemokines) with high selectivity through a two-site mechanism involving its N-terminal domain and juxtamembrane domain; upon ligand binding it activates Gi proteins (requiring the conserved DRY motif residue D134), triggers downstream signaling cascades (ERK1/2, AKT, PI3K, phospholipase C, Ca2+ flux), undergoes GRK2-mediated C-tail phosphorylation that drives β-arrestin recruitment and clathrin/dynamin-dependent internalization, and mediates critical neutrophil functions including transepithelial migration and degranulation-dependent bacterial/fungal killing, while forming homo- and heterodimers with CXCR2 that dynamically regulate signaling balance.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CXCR1 is a Gi-coupled chemokine receptor that selectively binds monomeric IL-8/CXCL8 through a two-site mechanism involving its N-terminal domain and transmembrane regions, activating downstream ERK1/2, AKT, phospholipase C, and Ca²⁺ signaling cascades to drive neutrophil chemotaxis, degranulation, and transepithelial migration [PMID:15133028, PMID:15252057, PMID:11046063, PMID:26791948]. Ligand-induced receptor desensitization requires GRK2-mediated C-tail phosphorylation at six key sites, which recruits β-arrestin and triggers clathrin/dynamin-dependent internalization, while the DRY motif residue D134 is essential for G-protein coupling and ligand binding [PMID:10347185, PMID:10623425, PMID:12626541, PMID:25834784]. CXCR1 forms homo- and heterodimers with CXCR2 whose balance is dynamically regulated by CXCL8, and it cross-phosphorylates CCR1 but is itself resistant to CCR1-mediated cross-desensitization, establishing an asymmetric chemokine receptor signaling hierarchy [PMID:19890050, PMID:10734056]. Beyond neutrophils, CXCR1 mediates neuronal Ca²⁺ channel modulation via Giα, drives dendritic cell inflammatory cytokine production through a CXCL5/HIF-1α feedback loop, regulates breast cancer stem cell survival via FAK/AKT/FOXO3A, and its proteolytic cleavage in cystic fibrosis airways disables neutrophil bactericidal capacity [PMID:11553670, PMID:37709757, PMID:20051626, PMID:18059279].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Establishing that CXCR1 surface expression is regulated independently of its own ligand: LPS down-modulates CXCR1 on neutrophils through an agonist-independent, tyrosine kinase (p72syk)-dependent mechanism, revealing that receptor availability is controlled by innate immune signals beyond IL-8.\",\n      \"evidence\": \"Flow cytometry on human neutrophils with tyrosine kinase inhibitors and p72syk phosphorylation western blot\",\n      \"pmids\": [\"9712063\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of kinases downstream of p72syk mediating receptor loss not determined\", \"Whether LPS causes receptor internalization vs. shedding vs. transcriptional suppression not fully resolved\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Defining the endocytic machinery for CXCR1: β-arrestin recruitment, GRK2-mediated phosphorylation, and dynamin/clathrin-dependent internalization were shown to be required, and the six C-terminal phosphorylation sites were identified as the primary internalization determinant—distinguishing CXCR1 from CXCR2 whose internalization relies on a membrane-proximal domain.\",\n      \"evidence\": \"Dominant-negative β-arrestin 1-V53D and dynamin K44A mutants in HEK293 and RBL-2H3 cells; C-tail truncation and phosphorylation-site mutants with recycling assays\",\n      \"pmids\": [\"10347185\", \"10623425\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific GRK2 phosphorylation sites within the six-site cluster not mapped individually\", \"Whether other GRKs contribute in primary neutrophils not addressed\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Revealing asymmetric cross-talk between chemokine receptors: IL-8/CXCR1 stimulation cross-phosphorylates and desensitizes CCR1, but CCR1 activation cannot reciprocally cross-desensitize CXCR1, establishing a signaling hierarchy among co-expressed chemokine receptors.\",\n      \"evidence\": \"RBL-2H3 cells co-expressing CCR1 with CXCR1 or CXCR2; receptor phosphorylation, GTPase, and Ca²⁺ assays with phosphorylation-deficient mutant controls\",\n      \"pmids\": [\"10734056\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinase responsible for heterologous CXCR1→CCR1 phosphorylation not identified\", \"Relevance of this hierarchy in primary neutrophils co-expressing multiple receptors not tested\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identifying CXCR1's non-redundant role in transepithelial neutrophil migration: antibody blockade and receptor knockout showed that CXCR1 (not CXCR2) on uroepithelial cells is required for neutrophil transmigration across infected mucosal barriers, linking CXCR1 to mucosal innate defense.\",\n      \"evidence\": \"Anti-CXCR1/CXCR2 blocking antibodies in epithelial migration assays; IL-8 receptor knockout mice with experimental UTI\",\n      \"pmids\": [\"11046063\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether epithelial CXCR1 acts by transcytosing IL-8 or by direct signaling in epithelial cells not resolved\", \"Contribution of CXCR1 on other mucosal surfaces not tested\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Demonstrating CXCR1 function outside the immune system: IL-8 acting through CXCR1 in cholinergic septal neurons closes L- and N-type Ca²⁺ channels via Giα1/Giα2, establishing that CXCR1 modulates neuronal excitability.\",\n      \"evidence\": \"Whole-cell patch clamp with single-cell RT-PCR from rat septal neurons; pharmacological G-protein subtype dissection\",\n      \"pmids\": [\"11553670\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Physiological role of CXCR1 in brain function not defined\", \"Whether neuronal CXCR1 undergoes the same internalization/desensitization as in immune cells unknown\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Mapping the intracellular domain architecture for G-protein signaling: the second intracellular loop of CXCR1 was identified as the major determinant of Gi-coupled ERK1/2 activation and chemotaxis through domain-swap chimeras with CXCR5.\",\n      \"evidence\": \"CXCR1/CXCR5 chimeric receptors assayed for pertussis toxin sensitivity, Ca²⁺ flux, ERK1/2 phosphorylation, and chemotaxis\",\n      \"pmids\": [\"11688722\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Specific residues within ICL2 mediating Gi coupling not identified\", \"Single-lab chimeric study without independent replication\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Dissecting the functional consequences of C-tail phosphorylation: phosphorylation-deficient mutants showed that C-tail phosphorylation is required for β-arrestin translocation and internalization but dispensable for—and actually inhibitory toward—phosphoinositide hydrolysis, exocytosis, and chemotaxis, uncoupling desensitization from effector function.\",\n      \"evidence\": \"Wild-type, chimeric, and phosphorylation-deficient CXCR1/CXCR2 mutants in RBL-2H3 cells with comprehensive signaling readouts\",\n      \"pmids\": [\"12626541\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether constitutive (non-ligand-dependent) phosphorylation occurs and affects basal trafficking not tested\", \"Role of individual phosphosites in graded β-arrestin recruitment not resolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Resolving the structural basis of ligand selectivity: NMR and biophysical studies showed that the CXCR1 N-terminal domain selectively binds the IL-8 monomer (not dimer) in a membrane-dependent conformation, with ITC quantifying binding affinity and establishing that IL-8 dimerization is a negative regulator of receptor engagement.\",\n      \"evidence\": \"NMR in detergent micelles; ITC and sedimentation equilibrium comparing IL-8 monomer vs. dimer binding to CXCR1 N-domain peptide\",\n      \"pmids\": [\"15133028\", \"15252057\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full-length receptor–ligand structure not determined\", \"How the N-domain binding step couples to TM domain activation (two-site mechanism) not structurally resolved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Establishing the agonist concentration threshold for internalization in primary neutrophils: receptor endocytosis requires ~10-fold higher IL-8 concentrations than chemotaxis and Ca²⁺ flux, and both receptors are excluded from lipid rafts, clarifying that internalization is a high-dose response separable from migration.\",\n      \"evidence\": \"Dose-response internalization, Ca²⁺ flux, and sucrose gradient fractionation in primary human neutrophils with clathrin/dynamin pathway inhibitors\",\n      \"pmids\": [\"15028716\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether sustained low-dose exposure eventually drives internalization not assessed\", \"Mechanism of lipid raft exclusion not defined\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Identifying the transmembrane allosteric binding pocket: repertaxin was shown to inhibit CXCR1 non-competitively by binding within the transmembrane region, validated by alanine scanning mutagenesis and photoaffinity labeling.\",\n      \"evidence\": \"Molecular modeling; systematic alanine mutagenesis of CXCR1 TM residues; photoaffinity labeling\",\n      \"pmids\": [\"15974585\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic-resolution structure of the repertaxin–CXCR1 complex not available\", \"Whether TM allosteric site is conserved across species not tested\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Linking CXCR1 proteolysis to impaired host defense in cystic fibrosis: neutrophil-surface CXCR1 cleavage by airway proteases abolished bacterial killing capacity (which required CXCR1 but not CXCR2), and shed CXCR1 fragments amplified inflammation via TLR2; α1-antitrypsin inhalation restored CXCR1 and bacterial killing in CF patients.\",\n      \"evidence\": \"Protease-treated neutrophils with bacterial killing assays; TLR2 stimulation by CXCR1 fragments; in vivo α1-antitrypsin inhalation in CF patients\",\n      \"pmids\": [\"18059279\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific protease(s) cleaving CXCR1 in CF airways not definitively identified\", \"Mechanism by which CXCR1 (but not CXCR2) supports bacterial killing not molecularly resolved\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Demonstrating receptor dimerization dynamics: FRET in primary neutrophils showed that CXCR1 forms homo- and heterodimers with CXCR2; CXCL8 stabilizes homodimers while remodeling heterodimeric complexes, indicating that oligomeric state is a regulatable signaling parameter.\",\n      \"evidence\": \"FRET measurements in human neutrophils and transfected cell lines under varying receptor expression and ligand conditions\",\n      \"pmids\": [\"19890050\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional consequence of homodimer vs. heterodimer signaling not determined\", \"Structural basis of dimer interface unknown\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Establishing CXCR1 as a breast cancer stem cell vulnerability: CXCR1 blockade depleted CSCs and triggered bystander apoptosis in bulk tumor cells through FASL/FAS signaling downstream of FAK/AKT/FOXO3A, positioning CXCR1 as a therapeutic target in breast cancer.\",\n      \"evidence\": \"CXCR1 blocking antibody and repertaxin in vitro and in human breast cancer xenografts; FAK/AKT/FOXO3A pathway inhibitor dissection\",\n      \"pmids\": [\"20051626\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CXCR1 marks a functionally distinct CSC subset or is universally expressed on CSCs unclear\", \"Mechanism linking CXCR1 blockade specifically to FASL upregulation not fully dissected\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Confirming the essential DRY motif and identifying a TM6 activation hotspot: D134 mutations abolished both ligand binding and signaling, while M241/F251 mutations on TM6 generated constitutive activity, mapping the structural requirements for CXCR1 activation.\",\n      \"evidence\": \"Site-directed mutagenesis with radioligand binding, Ca²⁺ mobilization, and G15 activation assays in transfected cells\",\n      \"pmids\": [\"25834784\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No full active-state structure to contextualize the TM6 mutations\", \"Whether TM6 constitutive-activity mutants signal through Gi or only promiscuous G15 not clarified\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Demonstrating CXCR1's non-redundant role in antifungal defense through degranulation: Cxcr1−/− mice had impaired neutrophil degranulation (not chemotaxis) and increased mortality in systemic candidiasis, and the human CXCR1-T276 variant recapitulated this degranulation defect, linking a specific cellular function to host antifungal immunity.\",\n      \"evidence\": \"Cxcr1−/− mouse systemic candidiasis model; neutrophil degranulation and trafficking assays; human CXCR1-T276 variant functional studies and genetic association\",\n      \"pmids\": [\"26791948\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signaling pathway connecting CXCR1 specifically to degranulation machinery not defined\", \"CXCR1-T276 patient cohort limited; broader replication needed\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identifying REEP5/REEP6 as CXCR1-specific accessory proteins: Co-IP showed these ER-shaping proteins interact selectively with CXCR1, facilitating its ligand-stimulated endocytosis, β-arrestin2 clustering, and downstream ERK signaling rather than surface trafficking.\",\n      \"evidence\": \"Co-immunoprecipitation; siRNA knockdown and overexpression of REEP5/6; CXCR1 internalization, β-arrestin2 clustering, and ERK phosphorylation assays\",\n      \"pmids\": [\"27966653\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Reciprocal Co-IP and endogenous interaction not confirmed\", \"Structural basis of REEP5/6 selectivity for CXCR1 over CXCR2 unknown\", \"Single-lab finding not independently replicated\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Extending CXCR1's role to dendritic cell biology: DC-specific CXCR1 knockout revealed a CXCL5/CXCR1/HIF-1α positive feedback loop driving IL-6/IL-12p70 production in inflammatory disease models (EAE, ARDS), expanding CXCR1 function beyond neutrophils.\",\n      \"evidence\": \"DC-specific CXCR1 knockout mice in EAE and LPS-ARDS models; cytokine profiling; HIF-1α pathway analysis; CXCL5 neutralization\",\n      \"pmids\": [\"37709757\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether HIF-1α is a direct transcriptional target of CXCR1 signaling or secondary to metabolic changes not resolved\", \"Single-lab finding; independent replication in other DC-driven disease models needed\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A high-resolution structure of CXCR1 in complex with monomeric IL-8 (or other ligands) and coupled G-protein has not been determined; the molecular basis for CXCR1's selective coupling to degranulation (but not chemotaxis) pathways, the identity of the protease(s) cleaving CXCR1 in disease airways, and the functional significance of CXCR1/CXCR2 dimer stoichiometry in vivo remain open questions.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No full-length CXCR1–IL-8–Gi cryo-EM or crystal structure\", \"Signaling branch point distinguishing degranulation from chemotaxis downstream of CXCR1 unknown\", \"CXCR1/CXCR2 heterodimer functional consequences in vivo undefined\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [8, 12, 17]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [18, 11]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 6, 11, 26]},\n      {\"term_id\": \"GO:0005768\", \"supporting_discovery_ids\": [0, 6, 29]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [0, 29]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [9, 16, 20, 31]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 13, 17, 19, 32]},\n      {\"term_id\": \"R-HSA-9609507\", \"supporting_discovery_ids\": [0, 1, 3, 6]}\n    ],\n    \"complexes\": [\n      \"CXCR1 homodimer\",\n      \"CXCR1/CXCR2 heterodimer\"\n    ],\n    \"partners\": [\n      \"CXCR2\",\n      \"ARRB1\",\n      \"ARRB2\",\n      \"GRK2\",\n      \"CXCL8\",\n      \"REEP5\",\n      \"REEP6\",\n      \"CCR1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}